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Abstract: The one-step synthesis of the bench-stable hypervalent 
iodine reagents IndoleBX and PyrroleBX using mild Lewis acid 
catalyzed conditions is reported. The new reagents are stable up to 
150 °C and were applied in the C-H arylation of unactivated arenes 
using either rhodium or ruthenium catalysts. A broad range of 
heterocyclic systems of high interest for synthetic and medicinal 
chemistry was accessed in high yields. The developed C-H 
functionalization could not be achieved using reported reagents or 
methods, highlighting the unique reactivity of Indole- and Pyrrole-BX. 
Pyrrole and indole heterocycles are omnipresent in natural and 
synthetic biologically active compounds and have found countless 
applications in the pharmaceutical and agrochemical industries.[1] 
Therefore, synthetic chemists have invested unceasing efforts 
towards their synthesis and functionalization.[2] As indoles and 
pyrroles are highly nucleophilic, the broad majority of 
functionalization methods is based on reactions with electrophiles, 
which limits the structural diversity of compounds in medicinal 
chemistry studies. In order to allow indoles and pyrroles to react 
with nucleophiles and discover new chemical space, an 
Umpolung of the innate reactivity of the heterocycles would be 
highly useful. However, accessing electrophilic indole and pyrrole 
synthons constitutes a formidable challenge. Most approaches 
rely on the substitution of the heterocycles with one or several 
electron-withdrawing groups or on reactive electrophilic indolyl 
intermediates generated in situ.[3] More stable halogenated 
indoles have been used only in cross-coupling reactions with 
activated partners.[4] Clearly, the development of better indole and 
pyrrole electrophilic synthons combining high reactivity with 
enhanced stability is needed. 
In this context, hypervalent iodine reagents are recognized 
for their high reactivity, which can lead to the formal Umpolung of 
functional groups.[5] The introduction of reactive yet stable aryl 
iodonium salts (Scheme 1A) has led to the development of 
broadly applicable arylation reactions.[6] Nevertheless, there are 
only few reports on indole and pyrrole-based iodonium salts. 
Pioneering works by Neiland, Kost, Moriarty and co-workers 
required a multi-step procedure via a potentially explosive betaine 
intermediate to access NH unprotected indole iodonium salts.[7] 
Recently, more stable indole and pyrrole iodonium salts  were 
reported by Moriyama and co-workers[8] and Kita and co-
workers[9] respectively, based on the introduction of an electron-
withdrawing group on the nitrogen. The electrophilic character of 
these reagents was used for direct reactions with nucleophiles, 
such as alkyl lithium reagents,[7c] azides,[10a] amines[10b] and 
electron-rich arenes.[9] There is only one report on the use of 
indole iodonium salts involving a transition metal: the copper-
catalyzed de-aromatization of indoles reported by You and co-
workers.[11] This stands in stark contrast with the hundreds of 
transformations reported for other aryl iodonium salts,[6] and is 
probably due to the lower stability of indole and pyrrole iodonium 
salts in presence of metals and/or at higher temperature.
 
Scheme 1. Aryliodonium salts, benziodoxolones and Indole/Pyrrole-BX 
reagents. 
The enhanced stability of cyclic hypervalent iodine reagents, 
in particular those obtained from 2-iodobenzoic acid and its 
derivatives – the benzidoxol(on)es - has been established since 
several decades (Scheme 1B).[12] The use of reagents such as 
benziodoxolones 1-3 in group-transfer reactions 
(trifluoromethylation, alkynylation and azidation) has been 
investigated only more recently.[13] In the short time since their 
introduction, they have already had a strong impact in the fields 
of synthetic and medicinal chemistry. Aryl benziodoxolones 4 
have also displayed enhanced stability and are easily accessible, 
but they have not found broad application in synthesis.[14] Indeed, 
in most reactions with nucleophiles, the benzoic acid group is 
transferred, limiting the scope of those transformations.[14c,15] 
There is no report on indole or pyrrole based benziodoxol(on)e 
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reagents, however, and the strongly acidic or oxidizing methods 
used for the introduction of other aryl groups cannot be used for 
these more sensitive heterocycles. 
Herein, we report the first synthesis of pyrrole- and indole- 
based benziodoxolone reagents in one step from the heterocycles, 
based on a mild zinc-catalyzed direct iodonium transfer from 
acetoxy benziodoxolone (5) (Scheme 1C). The new reagents are 
air- moisture- and thermally stable. They were applied in the 
directed ortho C-H functionalization of arenes using rhodium and 
ruthenium catalysts, resulting in bond formations that could not be 
achieved using reported methods and reagents. 
To access the targeted Indole- and Pyrrole-BX reagents, we 
first applied recently reported methods for aryl benziodoxolone 
synthesis based on the oxidation of iodobenzoic acid (6) followed 
by reaction with N-methyl indole (8a) in presence of triflic or 
sulfuric acid (Table 1, entries 1-2).[14] However, only 
decomposition of the indole was observed. To avoid the use of 
oxidants, iodine(III) precursors were then examined. Starting from 
hydroxy benziodoxolone 7 with trimethylsilyl triflate (TMSOTf) as 
activating agent,[16] decomposition was still occurring (entry 3). If 
a lower amount of TMSOTf was used, no conversion was 
observed (entry 4). A promising result was obtained with acetoxy 
benziodoxolone 5 as precursor: the desired indole-BX could be 
obtained in 16% yield using 20 mol% of TMSOTf (entries 5 and 
6).[17]  This compound could be purified by silica gel column 
chromatography and was thermally stable up to 150 °C.[18] No 
conversion was observed in absence of TMSOTf (entry 7). Better 
results were obtained with Zn(OTf)2 and Cu(OTf)2 as Lewis acids 
(entries 8 and 9), giving 9a in 36% yield. Changing to 
dichloromethane as solvent with Zn(OTf)2 as catalyst, 9a was 
obtained in 97% yield with complete C3 selectivity (entry 10). This 
synthesis could be easily scaled up to give 9a in 87% yield on the 
10 mmol scale (entry 11). 
Table 1. Optimization of the synthesis of Indole-BX 9a. 
 
Entry Iodine precursor Reaction Conditions[a] Yield[b] (%) 
1 6 mCPBA, TfOH, CH2Cl2, then NH3[14b] <5[c] 
2 6 Oxone, H2SO4, CH2Cl2, then NaHCO3[14c] <5[c] 
3 7 1 equiv TMSOTf, CH3CN, then pyridine <5[c] 
4 7 20 mol% TMSOTf, CH3CN <5[d] 
5 5 1 equiv TMSOTf, Et2O <5[c] 
6 5 20 mol% TMSOTf, Et2O 16 
7 5 Et2O <5[d] 
8 5 20 mol% Zn(OTf)2, Et2O 36 
9 5 20 mol% Cu(OTf)2, Et2O 36[c] 
10 5 20 mol% Zn(OTf)2, CH2Cl2 97 
11 5 20 mol% Zn(OTf)2, CH2Cl2 87[e] 
[a] Reactions were performed on 0.10 mmol scale with 1.1 equiv of iodine 
precursor. [b] Isolated yield after purification by column chromatography. [c] 
Decomposition of N-methylindole (8a) was observed. [d] No conversion of 7 or 
8a. [e] Reaction performed on 10 mmol scale. 
Free NH IndoleBX 9b could be also synthesized in 78% 
yield starting from N-silylated indole (Figure 1). The hypervalent 
structure of this compound was confirmed by X-ray analysis.[18] 
Different alkyl groups on the nitrogen were well tolerated (9c-e). 
Reagent 9f bearing a C2-substituted indole was also obtained in 
good yield, but no conversion was observed with C3-substitution. 
Arenes bearing ethers (9g), halogens (9h-j) and a sensitive 
boronic ester (9k) could also be used. Reagent 9l derived from a 
less reactive azaindole was still isolated in 30% yield. PyrroleBX 
9m-q were also successfully synthesized. When starting from N-
silylated pyrrole, a complete C3 regioselectivity was achieved 
(9m). When methyl-and benzyl-pyrrole where used as substrates, 
mixtures of separable C2:C3 functionalized reagents were 
obtained. The availability of both isomers in pure form opened the 
way for the selective synthesis of C2- or C3- functionalized 
pyrroles by reaction with nucleophiles. The synthesis of new 
pyrrole and indole electrophilic synthons is especially important, 
as none of the currently available reagents can be used in C-H 
functionalization reactions, in contrast to other classes of 
heterocycles. Nevertheless, the use of other electron-rich 
aromatic compounds could also be envisaged. Indeed, carbazole-
BX 9r, thiophene-BX 9s and furan-BX 9t were also obtained in 
low to moderate yields without further optimization. 
 
Figure 1. Scope of heteroaromatic benziodoxole reagents. Reaction conditions: 
1.00 mmol heterocycle, 1.10 mmol 5, 0.200 mmol Zn(OTf)2, 0.05 M in DCM, RT, 
open air. Isolated yields. [a] Sc(OTf)3 was used starting from N-TBS heterocycle. 
[b] Sc(OTf)3 was used. [c] In(OTf)3 was used. 
Preliminary investigations showed that the reactivity of indole-BX 
9a differed from the one of both aryliodonium salts and EBX 
reagents (Scheme 2). The reaction of EBX reagents and 
aryliodonium salts with thiols, alcohols and stabilized carbon 
nucleophiles in presence of base is well established,[19] but no 
reaction occurred with 9a. In the case of thiol 10, a moderate yield 
of thiol indolation product 11 could be obtained in presence of a 
copper catalyst (Scheme 2A). Palladium-catalyzed C-H bond 
arylation,[6a,20] was also unsuccessful. In contrast, highly efficient 
C-H functionalizations could be developed using either rhodium- 





or ruthenium catalysts.[21] Importantly, complete and selective 
transfer of the indole was obtained to give 13a and 15a, with no 
coupling of benzoic acid. 
 
Scheme 2. Preliminary studies of the reactivity of Indole-BX 9a. Reaction 
conditions: a) 10, 20 mol% CuOTf•C6H6, CH2Cl2, RT; b) 12, 2.5 mol% 
[Rh(Cp*Cl2)]2, 10 mol% NaOPiv, 10 mol% AgSbF6, DCE, 0.1 M, 50 °C; c) 14, 
10 mol% Ru[p-cymene(AdCOO)2],[22] trifluoroethanol, 0.1 M, 60 °C. [a] See 
supporting Information for detailed reaction conditions. 
The latter results are especially interesting, as the introduction of 
an indole on a benzene C-H bond in ortho position to a pyridine 
or a benzamide has never been reported. This is surprising, as 
ortho C-H bond functionalization in arenes is now considered as 
a mature field.[23] When considering the high importance of indole 
and pyrrole heterocycles in synthetic and medicinal chemistry, 
realizing such a transformation would be an important 
breakthrough in the field. We wondered therefore if established 
methods for the introduction of indoles onto other types of C-H 
bonds could be used to access products 13a and 15a. However, 
when reported methods for C-H indolation based on oxidative C-
H/C-H couplings[24-26] with indole 8a or C-H functionalization with 
electrophilic indoles 16, 17 and 18,[18] were examined, 
compounds 13a and 15a could not be obtained (Scheme 2B). 
Therefore, the discovery of Indole-BX reagents allowed new C-H 
functionalizations which were not possible before. 
The scope of the rhodium-catalyzed C-H functionalization was 
then examined (Scheme 3A). Indoles 13b and 13c bearing either 
a free NH group or an alkyl chain were obtained in good yield. 
Ethers, halogens and a sensitive boronic ester were well tolerated 
on the benzene ring of the indole reagent (13d-h). The 
regioselective synthesis of both C2 and C3 substituted pyrroles 
was possible (13i-m).[27] Methoxy, halogens, esters and cyanides 
functional groups could be present on the arene substrate (13n-
r). Diarylation was also possible using an excess of reagent 8a to 
give product 19. Good results were also obtained with other 
heterocyclic directing groups such as pyrimidine (20) or pyrazole 
(21). Benzoquinoline 22 and pyrimidine-substituted indole 23 
were also formed in good yield. When quinoline N-oxide was used 
as the starting material, quinolone 24 was obtained in 38% yield. 
The developed C-H arylation could also be applied to a purine-
based nucleoside to give product 25.  
 
Scheme 3. Scope of the Rh- and Ru- catalyzed C-H Functionalizations. 
Reactions were performed on 0.30 mmol scale. [a] 0.1 M in DCE:MeOH (1:1 
ratio). [b] at 80 °C. [c] Using 0.660 mmol 8a. [d] at 100 °C.  





The thermal stability of the developed reagents was essential to 
achieve a broad scope, as several substrates required higher 
temperature to reach useful conversion (80 °C for products 
13c,k,l,r, 20 and 21, and 100 °C for compound 24). Preliminary 
investigations of the scope of the ruthenium-catalyzed C-H 
functionalization were then conducted (Scheme 3B). The 
benzamide directing group is attractive, as it can be easily 
modified or removed. Alkyl groups, ethers, trifluoromethyl groups 
and halogens were all well tolerated both in para and meta 
position to the amide (15a-i). Tetrasubstituted arene 15j and 
naphthyl derivatives 15k were also obtained in good yields. 
In conclusion, we have reported the first synthesis of indole- and 
pyrrole substituted benziodoxolone reagents. Indole- and Pyrrole-
BX were synthesized in one-step from the heterocycles under 
mild Lewis acid catalyzed conditions and are thermally stable up 
to 150 °C. These new reagents can be used for the Rh- and Ru- 
ortho C-H functionalization of arenes using heterocyclic and 
benzamide directing groups, a transformation that could not be 
realized using previously reported methods. Many of the obtained 
products are new combinations of privileged (hetero)arenes, 
covering interesting chemical space for medicinal chemistry. The 
availability of stable electrophilic indole and pyrrole synthons is 
expected to lead to broad applications in synthetic and medicinal 
chemistry. 
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1. Materials and Methods. 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography, technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). The solvents were degassed 
through Freeze-Pump-Thaw method when mentioned. All chemicals were purchased from Acros, 
Aldrich, Fluka, VWR, Aplichem, or Merck and used as such unless otherwise stated. 
Chromatographic purification was performed as flash chromatography using Macherey-Nagel 
silica 40-63, 60 Å, with the solvents indicated as eluent under 0.1-0.5 bar pressure. TLC was 
performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates and visualized with 
UV light, permanganate stain, CAN stain, or Anisaldehyde stain. Melting points were measured on 
a Büchi B-540 melting point apparatus using open glass capillaries, the data is uncorrected. 1H-
NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in CDCl3, DMSO-d6 
CD3OD, C6D6 and CD2Cl2, all signals are reported in ppm with the internal chloroform signal at 
7.26 ppm, the internal DMSO signal at 2.50 ppm the internal methanol signal at 3.30 ppm, the 
internal dichloromethane signal at 5.30 ppm as standard. The data is being reported as (s = singlet, 
d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, 
app = apparent, coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were 
recorded with 1H-decoupling on a Brucker DPX-400 100 MHz spectrometer in CDCl3, DMSO-d6, 
CD3OD or CD2Cl2, all signals are reported in ppm with the internal chloroform signal at 77.0 ppm, 
the internal DMSO signal at 39.5 ppm, the internal methanol signal at 49.0 ppm and the internal 
dichloromethane signal at 54.0 ppm as standard. Infrared spectra were recorded on a JASCO FT-
IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 
(w = weak, m = medium, s = strong, br = broad). High resolution mass spectrometric 
measurements were performed by the mass spectrometry service of ISIC at the EPFL on a 





2. Preparation of PyrroleBXs and IndoleBXs.  
The synthesis of the precursors for HeterocyclicBX reagents (7 and 5) 9a-9r had been already 
described before. 1,2 The procedures here reported are taken from the cited publications to facilitate 
reproduction of the results by having all the data in the same file. 
2.1 Preparation of Starting Materials for PyrroleBXs and IndoleBXs. 
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (27) 
 
Following a reported procedure, NaIO4 26 (7.24 g, 33.8 mmol, 1.05 equiv) and 2-iodobenzoic acid 
6 (8.00 g, 32.2 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH (48 mL). The mixture 
was vigorously stirred and refluxed for 4 h. The reaction mixture was then diluted with cold water 
(180 mL) and allowed to cool to room temperature, protecting it from light. After 1 h, the crude 
product was collected by filtration, washed on the filter with ice water (3 x 20 mL) and acetone (3 
x 20 mL), and air-dried in the dark to give the pure product 7 (8.30 g, 31.0 mmol, 98% yield) as a 
colorless solid. 1H NMR (400 MHz, DMSO-d6): δ 8.02 (dd, J = 7.7, 1.4 Hz, 1H, ArH), 7.97 (m, 
1H, ArH), 7.85 (dd, J = 8.2, 0.7 Hz, 1H, ArH), 7.71 (td, J = 7.6, 1.2 Hz, 1H, ArH). 13C NMR (100 
MHz, (CD3)2SO): δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4. IR ν 3083 (w), 3060 (w), 2867 
(w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 (s), 1302 (m), 1148 (m), 1018 (w), 
834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m). NMR values are in accordance with the data 
reported in literature.1 
 
1-Acetoxy-1,2-benziodoxol-3-(1H)-one (4)  
                                                 
[1] D. P. Hari, J. Waser, J. Am. Chem. Soc. 2016, 138, 2190–2193. 





Following a reported procedure,3 1-hydroxy-1,2-benziodoxol-3-(1H)-one 7, 10.3 g, 39.1 mmol, 
1.00 equiv.) was suspended in acetic anhydride 27 (35 mL) and heated to reflux for 30 minutes. 
The resulting clear, slightly yellow solution was slowly let to warm up to room temperature and 
then cooled to 0 °C for 30 minutes. The white suspension was filtered and the filtrate was again 
cooled to 0 °C for 30 minutes. The suspension was once again filtered and the combined two 
batches of solid product were washed with hexane (2 x 20 mL) and dried in vacuo to afford 1-
Acetoxy-1,2-benziodoxol-3-(1H)-one 5 (10.8 g, 35.3 mmol, 90%) as a white solid.  1H NMR 
(CDCl3, 400 MHz) δ 8.24 (dd, J = 7.6, 1.6 Hz, 1H, ArH), 8.00 (dd, J = 8.3, 1.0 Hz, 1H, ArH), 7.92 
(ddd, J = 8.4, 7.2, 1.6 Hz, 1H, ArH), 7.71 (td, J = 7.3, 1.1 Hz, 1H, ArH), 2.25 (s, 3 H, COCH3). 13C 
NMR (CDCl3, 100 MHz) δ 176.5, 168.2, 136.2, 133.3, 131.4, 129.4, 129.1, 118.4, 20.4. NMR 
values are in accordance with the data reported in literature.4 
 
General Procedure GP1 for the N-Methylation of Indoles. 
 
The corresponding indole (1.00 - 5.00 mmol, 1.00 equiv.) was dissolved in dry THF (0.3 M). 
Sodium hydride (60% suspension in mineral oil; 1.50 equiv.) was slowly added under N2 flow at 0 
°C. After being stirred at 0 °C for 15 min,the reaction mixture was allowed to warm to r.t for 1.5 
h. It was then cooled back to 0 °C and methyl iodide (1.30 equiv.) was added. The mixture was 
warmed to r.t. and stirred overnight. After cooling again to 0° C, the reaction was quenched with 
water (10 mL), extracted with Et2O (3 x 10 mL), the combined organic layers were dried over 
MgSO4, and the solvent removed under reduced pressure. The resulting crude product was purified 
via flash column chromatography (Pentane:EtOAc 9:1-4:1), to give the desired N-methylated 
indole. 
                                                 
[3] A. T. Parsons, S. L. Buchwald, Angew. Chem. Int. Ed. 2011, 50, 9120–9123 





Starting from commercially available 2-methylindole (656 mg, 5.00 mmol), 1,2-
dimethyl-1H-indole 28 (683 mg, 4.70 mmol, 94% yield) was obtained as an off-
white solid. 1H NMR (400 MHz CDCl3) δ 7.69 (d, J = 7.8 Hz, 1H, ArH), 7.41 
(dd, J = 8.1, 1.0 Hz, ArH), 7.32 (m, 1H, ArH), 7.24 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, 
ArH), 6.42 (s, 1H, NC(CH3)CH), 3.79 (s, 3H, NCH3), 2.57 (d, J = 1.0 Hz, 3H, NCCH3). 13C NMR 
(125 MHz, CDCl3) δ  138.1, 136.9, 128.1, 120.6, 119.8, 119.4, 108.8, 99.7, 29.5, 12.9. IR ν (neat) 
3050 (w), 3020 (w), 2970 (m), 1610 (w), 1400 (s), 1340 (m), 1240 (m), 930 (m), 910 (w), 780 (m), 
750 (m), 730 (s). 1H NMR values are in accordance with the data reported in literature.4 
 
5-Methoxy-1-methyl-1H-indole (29) 
Starting from commercially available 5-methoxy-1H-indole (736 mg, 5.00 
mmol), 5-methoxy-1-methyl-1H-indole 29 (730 mg, 4.53 mmol, 91% yield) 
was obtained as a colorless crystalline solid. 1H NMR (400 MHz, CDCl3) δ δ 
7.30 (d, 1H, J = 8.5 Hz, ArH) 7.13 (s, 1H, ArH), 7.05 (s, 1 H, ArH), 6.92 (d, 
1H, J = 8.8 Hz, ArH), 6.43 (d, 1H, J = 1.0 Hz, ArH), 3.90 (s, 3H, NMe), 3.80 (s, 3H, OMe). 13C 
NMR (101 MHz, CDCl3) δ 154.0, 132.2, 129.3, 128.8, 111.9, 109.9, 102.5, 100.4, 55.9, 33.0. IR 
ν 2952 (w), 2918 (w), 2834 (w), 1622 (m), 1608 (w), 1577 (w), 1496 (s), 1459 (w), 1450 (m), 1449 
(m), 1421 (s), 1347 (w), 1293 (w), 1243 (s), 1191 (m), 1152 (s), 1102 (w), 1026 (m), 942 (w), 855 





Starting from commercially available 5-fluoro-1H-indole (676 mg, 5.00 mmol), 5-
fluoro-1-methyl-1H-indole 30 (683 mg, 4.58 mmol, 92% yield) was obtained as a 
colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.31 (dd, J = 9.7, 2.4 Hz, 1H, ArH), 
7.26 (m, 1H, ArH), 7.12 (d, J = 3.1 Hz, 1H, ArH), 7.01 (dt, J = 9.1, 2 Hz, 1H, 
ArH), 6.48 (dd, J = 3.1, 0.7 Hz, 1H, ArH). 3.81 (s, 3H, NCH3) 13C NMR (101 MHz, CDCl3) δ 
158.0 (d, J-F6 = 232 Hz), 133.4, 130.4, 128.7 (d, J-F6 = 10 Hz), 109.9 (d, J-F6 = 15 Hz), 109.8, 
105.5 (d, J-F6 = 23 Hz), 100.8 (d, J-F6 = 5.0 Hz), 33.1. IR 3104 (w), 2946 (w), 2922 (w), 2907 (w), 
2887 (w), 2362 (w), 2343 (w), 1626 (w), 1576 (w), 1514 (m), 1492 (s), 1449 (m), 1423 (m), 1340 (m), 
1283 (m), 1238 (s), 1228 (s), 1140 (m), 1129 (m), 1122 (m), 1100 (m), 1081 (m), 1013 (w), 949 (m), 
859 (m), 811 (s). 
 
5-Chloro-1-methyl-1H-indole (31) 
Starting from commercially available 5-chloro-1H-indole (758 mg, 5.00 mmol), 
5-chloro-1-methyl-1H-indole 31 (800 mg, 4.83 mmol, 97% yield) was obtained 
as a colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 2.1 Hz, 1H, ArH), 
7.30 – 7.19 (m, 2H, ArH), 7.10 (d, J = 3.1 Hz, 1H, ArH), 6.47 (dd, J = 3.1, 0.7 
Hz, 1H, ArH), 3.80 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 135.1, 130.1, 130.1, 125.1, 
121.8, 120.2, 110.2, 100.6, 33.1. IR ν 3102 (w), 2943 (w), 2913 (w), 2881 (w), 2817 (w), 1567 
(w), 1513 (m), 1475 (s), 1441 (m), 1421 (s), 1379 (w), 1331 (m), 1278 (s), 1241 (s), 1199 (m), 
1146 (m), 1106 (w), 1082 (m), 1063 (s), 1009 (m), 909 (m), 870 (m), 869 (m). 
 
5-Iodo-1H-indole (32) 
Starting from commercially available 5-iodo-1H-indole (257 mg, 1.00 mmol), 5-
iodo-1-methyl-1H-indole 32 (380 mg, 0.755 mmol, 76% yield) was obtained as a 
colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.98 (s, 1 H, ArH), 7.49 (d, J = 8.6 
Hz, 1H, ArH), 7.13 (d, J = 8.6 Hz, 1H, ArH), 7.04 (s, 1H, ArH), 6.43 (s, 1H, ArH), 
3.80 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 135.8, 131.0, 129.8, 129.7, 129.6, 111.3, 100.3, 
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82.9, 33.0.  IR ν 3093 (w), 3053 (w), 2940 (w), 2919 (w), 2886 (w), 2876 (w), 2856 (w), 1557 (m), 
1510 (s), 1473 (s), 1432 (m), 1420 (s), 1379 (w), 1329 (m), 1277 (s), 1242 (s), 1193 (w), 1151 (w), 







Following a reported procedure,5 commercially available 1H-pyrrole 33 (700 µl, 10.0 mmol) was 
dissolved in dry THF (30 ml, 0.3 M). Sodium hydride (60% suspension in mineral oil; 600 mg, 
15.0 mmol, 1.50 equiv.) was slowly added under N2 flow at 0 °C. After being stirred at 0°C for 15 
                                                 
[5] A. F. G. Maier, S. Tussing, T. Schneider, U. Flörke, Z.-W. Qu, S. Grimme, J. Paradies, Angew. Chem. Int. Ed. 




min, the reaction mixture was allowed to warm to r.t for 1.50 h. Then it was cooled back to 0°C 
and tert-butylchlorodimethylsilane (1.96 g, 13.0 mmol, 1.30 equiv.) was added. The mixture was 
warmed to r.t. and stirred overnight. The reaction was quenched by addition of water (10 mL) at 
0°C. The aqueous layer was extracted with Et2O (3 x 10 mL), the combined organic layers were 
dried over MgSO4, and the solvent was removed under reduced pressure. The crude product was 
purified via flash column chromatography (Pentane:EtOAc 8:1), to give the desired 1-(tert-
butyldimethylsilyl)-1H-pyrrole 35 (1.30 g, 7.17 mmol, 72% yield). 1H NMR (400 MHz, CDCl3) δ 
6.86 – 6.62 (m, 2H, ArH), 6.39 – 6.21 (m, 2H, ArH), 0.86 (s, 9H, SiC(CH3)3), 0.41 (s, 6H, 
Si(CH3)2). IR ν 3100 (w), 2956 (m), 2931 (m), 2858 (m), 1707 (w), 1473 (m), 1364 (w), 1259 (s), 
1222 (w), 1190 (s), 1084 (s), 1048 (s), 1008 (w), 942 (w), 839 (s). 1H NMR values are in accordance 




Following a reported procedure,7 commercially available 1H-indole 34 (586 mg, 5.00 mmol) was 
dissolved in dry THF (10 mL, 0.5 M). Sodium hydride (60% suspension in mineral oil; 300 mg, 
7.50 mmol, 1.50 equiv.) was slowly added under N2 atmosphere at 0 °C. After being stirred at 0 
°C for 15 min, the reaction mixture was allowed to warm to r.t for 1.5 h. Then it was cooled back 
to 0 °C and tert-butylchlorodimethylsilane (980 mg, 6.50 mmol, 1.30 equiv.) was added. The 
mixture was warmed to r.t. and stirred overnight. After cooling again to 0 °C, the reaction was 
quenched with water (10 mL), extracted with Et2O (3 x 10 mL), the combined organic layers were 
dried over MgSO4, and the solvent was removed under reduced pressure. The residue was purified 
via flash column chromatography (Pentane:EtOAc 4:1), to give the desired 1-(tert-
butyldimethylsilyl)-1H-indole 36 (869 mg, 3.76 mmol, 75% yield). 1H NMR (400 MHz, CDCl3) 
                                                 
[6] G. Simchen, M. W. Majchrzak, Tetrahedron Lett. 1985, 26, 5035–5036. 
[7] S. Islam, I. Larrosa, Chem. – Eur. J. 2013, 19, 15093–15096 
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δ 7.79 (m, 1H, ArH), 7.72 (dt, J = 8.2, 1.1 Hz, 1H, ArH), 7.37 (d, J = 3.2 Hz, 1H, ArH), 7.32 (ddd, 
J = 8.3, 7.0, 1.6 Hz, 1H, ArH), 7.25 (m, 1H), 6.78 (dd, J = 3.3, 1.0 Hz, 1H, ArH), 1.11 (s, 9H, 
SiCCH3), 0.78 (s, 6H, Si(CH3)2). IR ν 3064.6 (w), 2950.5 (w), 2929.7 (m), 2855.9 (w), 1512.0 (s), 
1427.6 (s), 1449.9 (m), 1284.3 (s), 1271.6 (s), 1255.8 (m), 1158.9 (s), 1140.9 (s), 984.2 (w), 840.1 




Following a reported procedure,9 potassium tertbutoxide (1.24 mg, 11.0 mmol, 1.10 equiv.) was 
added to a solution of 18-crown-6 ether (26.4 mg, 0.100 mmol, 10 mol%.) in dry THF (25 mL, 0.4 
M) under a nitrogen atmosphere. Then, commercially available 1H-indole 34 (1.17 g, 10.0 mmol, 
1.00 equiv.) was added under vigorous stirring. The reaction was cooled to 0°C in an ice bath. A 
solution of 4-bromobut-1-ene (1.20 mL, 11.0 mmol, 1.10 equiv.) in THF (5 mL) was added 
dropwise to the reaction mixture and the latter was stirred overnight. After cooling again to 0 °C, 
the reaction was quenched with water (20 mL), extracted with Et2O (3 x 20 mL), the combined 
organic layers were dried over MgSO4, and the solvent was removed under reduced pressure. The 
residue was purified via flash column chromatography (Pentane:EtOAc 9:1) to give the desired 1-
(but-3-en-1-yl)-1H-indole 37 (280 mg, 1.64 mmol, 17% yield) as a yellow oil. 1H NMR (400 MHz, 
CDCl3) δ 7.84 (d, J = 8.0 Hz, 1H, ArH), 7.52 (d, J = 8.2 Hz, 1H, ArH), 7.41 (t, J = 7.6 Hz, 1H, 
ArH), 7.31 (t, J = 7.4 Hz, 1H, ArH), 7.23 (d, J = 3.2 Hz, 1H, ArH), 6.68 (d, J = 3.2 Hz, 1H, ArH), 
5.94 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H, ArH), 5.32 – 5.12 (m, 2H, NCH2CH2CH=CH2), 4.31 – 4.27 
(m, 2H, CH2), 2.72 (q, J = 7.1 Hz, 2H, CH2). IR ν 2936 (w), 1640 (s), 1612 (s), 1508 (m), 1458 
                                                 
[8] D. Saha, R. Ghosh, A. Sarkar, Tetrahedron 2013, 69, 3951–3960. 
[9] W. C. Guida, D. J. Mathre, J. Org. Chem. 1980, 45, 3172–3176. 
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(s), 910 (m), 740 (m), 712 (m). 1H NMR values are in accordance with the data reported in 
literature.10 
(2-Iodoethoxy)triisopropylsilane (38)  
 
Following a reported procedure,11 commercially available 2-iodoethanol 38 (1.10 mL, 10.0 mmol, 
1.00 equiv.) was added to a solution of imidazole (885 mg, 13.0 mmol, 1.30 equiv.) in DMF (5 
mL, 2.0 M) under nitrogen atmosphere. chloro-triisopropylsilane (2.80 mL, 13.0 mmol, 1.30 equiv.) 
was then added dropwise. After 1 h, the reaction turned into a thick suspension and a colorless 
solid precipitated. The mixture was allowed to warm to room temperature removed and was stirred 
for an additional hour. Water (5 mL) was added to dissolve the solid. The organic layer was 
separated and eluted through a SiO2 plug with pentane (100 mL). The solvent was removed under 
reduced pressure to give (2-iodoethoxy)triisopropylsilane 39 (3.15 g, 9.60 mmol, 96% yield) as a 
slightly yellow oil. 1H NMR (400 MHz, CDCl3) δ 3.85 (t, J = 6.9 Hz, 2H, OCH2), 3.15 (t, J = 7.0 
Hz, 2H, ICH2), 1.11-0.88 (m, 21H, TIPS). 13C NMR (101 MHz, CDCl3) δ 64.6, 18.0, 12.1, 6.9. IR 
ν 2958 (m), 2942 (m), 2891 (w), 2866 (m), 1464 (m), 1384 (w), 1275 (w), 1249 (w), 1190 (w), 
1169 (w), 1123 (s), 1092 (s), 1069 (s), 1013 (w), 999 (m), 943 (w), 920 (w), 882 (s), 857 (w). 
 
1-(2-((Triisopropylsilyl)oxy)ethyl)- 1H-Indole (40) 
 
                                                 
[10] H. A. Kerchner, J. Montgomery, Org. Lett. 2016, 18, 5760–5763. 
 
[11] J. W. Bode, E. M. Carreira, J. Org. Chem. 2001, 66, 6410–6424. 
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Commercially available 1H-indole 34 (586 mg, 5.00 mmol) was dissolved in N,N-
dimethylformamide (5 mL, 0.5 M in total). Sodium hydride (60% suspension in mineral oil; 144 
mg, 6.00 mmol, 1.20 equiv.) was added at r.t. and the reaction mixture was stirred for one hour. 
N,N-Dimethylformamide (5 mL) was then added to dissolve the resulting colorless precipitate. The 
reaction was cooled to 0 °C and (2-iodoethoxy)triisopropylsilane 39 (1.90 g, 5.50 mmol, 1.10 
equiv.) was added dropwise. The reaction mixture was stirred overnight, allowing it to warm to r.t. 
The reaction was then quenched with water (20 mL) and the reaction mixture was extracted with 
EtOAc (3 x 25 mL). The combined organic layers were washed with water (10 mL), brine (3x10 
mL), and dried over MgSO4. The solvent was then removed under reduced pressure. Flash column 
chromatography (Pentane:EtOAc 9:1) afforded 1-(2-((triisopropylsilyl)oxy)ethyl)- 1H-indole 40 
(1.20 g, 3.78 mmol, 76% yield) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.66 (m, 1 H, 
ArH), 7.38 (dd, J = 8.2, 0.8 Hz, 1H, ArH), 7.25 - 7.19 (m, 2H, ArH), 7.13 (m, 1H, ArH), 6.52 (dd, 
J = 3.1, 0.8 Hz, 1H, ArH), 4.30 (t, J = 6.0 Hz, 2H, CH2), 4.04 (t, J = 5.8 Hz, 2H, CH2), 1.17 - 0.85 
(m, 21H, TIPS). 13C NMR (101 MHz, CDCl3) δ 136.1, 128.7, 128.6, 121.3, 120.9, 119.2, 109.3, 
101.0, 62.8, 48.8, 17.9, 11.9. IR ν 3056 (w), 2891 (m), 2865 (s), 1514 (w), 1464 (s), 1439 (w), 
1387 (w), 1360 (w), 1334 (w), 1317 (m), 1115 (s), 1077 (m), 1013 (m), 923 (m), 819 (w).  
1-(3-Phenylpropyl)-1H-indole (41)  
 
Following a reported procedure (12), commercially available 1H-indole 34 (585 mg, 5.00 mmol, 
1.00 equiv.) was dissolved in THF (15 mL). Sodium hydride (60% suspension in mineral oil; 300 
mg, 7.50 mmol, 1.50 equiv.) was added at 0 °C and the reaction mixture was stirred for 30 min. (3-
bromopropyl)benzene (760 µL, 5.00 mmol, 1.00 equiv.) was then added dropwise. After 15 min 
the ice bath was removed and the reaction mixture was stirred for 4 hours at r.t.. The reaction was 
cooled back to 0 °C, quenched with water, diluted with EtOAc (10 mL), extracted with water (2 x 
10 mL), washed with brine (10 mL), and dried over MgSO4. After filtration, the solvent was 
                                                 
[12] Y. R. Jorapur, J. M. Jeong, D. Y. Chi, Tetrahedron Lett. 2006, 47, 2435–2438. 
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removed under reduced pressure. Flash column chromatography (Pentane:EtOAc 20:1) afforded 
1-(3-phenylpropyl)-1H-indole 41 (1.12 g, 4.76 mmol, 95% yield) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 7.87 (d, J = 8 Hz, 1H, ArH), 7.53-7.23 (m, 9H, ArH), 6.72 (dd, J = 3.1, 0.8 Hz, 
1H, ArH), 4.26 (t, J = 7.1 Hz, 2H, NCH2), 2.77 (t, J = 8 Hz, 2H, CH2Ph), 2.34 (qi, J = 7.8 Hz, 2H, 
CH2CH2CH2). 13C NMR (101 MHz, CDCl3) δ 141.2, 136.2, 128.7, 128.7, 128.6, 128.0, 126.3, 
121.6, 121.2, 119.5, 109.6, 101.3, 45.8, 33.2, 31.7 (one aromatic Carbon signal not resolved). IR 
3085 (w), 3057 (w), 3026 (w), 3004 (w), 2946 (w), 2945 (w), 2870 (w), 1780 (w), 1738 (s), 1717 
(s), 1612 (w), 1603 (w), 1511 (m), 1497 (m), 1483 (m), 1464 (s), 1455 (s), 1400 (m), 1377 (s), 
1354 (s), 1336 (s), 1315 (s), 1254 (s), 1207 (s), 1179 (m), 1166 (m), 1143 (m), 1143 (m), 1122 (m), 
1114 (m), 1080 (m), 1031 (m), 1020 (m), 1004 (w), 952 (w), 928 (w), 909 (w), 885 (m), 855 (w), 





2.2 Optimization in the synthesis of IndoleBX 9a. 
Table S1: Screening of additives 
 
Entry Reagent Additive Yield%a 
1 HOBX (7) TMSOTf -b 
2 HOBX (7) Zn(OTf)2 -b 
3 AcOBX (5) - -b 
4 AcOBX (5) TMSOTf 16% 
5 AcOBX (5) Zn(OTf)2 36%b 
6 AcOBX (5) Cu(OTf)2 36%c 
7 AcOBX (5) AgNTf2 -c 
8 AcOBX (5) AgF -c 
9 AcOBX (5) CsF -c 
10 AcOBX (5) TBAF -c 
a) Substrate 8a (0.100 mmol), reagents 7-5 (0.110 mmol), additive (20 mol%), and Et2O (0.05 M) 
at 25 °C. Isolated yield after flash chromatography is given. b) No conversion: starting materials 
recovered. c) Complete decomposition of the hypervalent iodine reagents. 
 
Table S2: Screening of solvents and additive loading 
Entry Solvent X mol% Zn(OTf)3 Yield%a 
1 THF 10 -b 
2 THF 20 -b 
3 THF 1 equiv. -b 
4 DCM 10 Full conversionc 
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5 DCM 20 97% 
6 DCM 1 equiv. decomposition 
a) Substrate 8a (0.100 mmol), AcOBX 5 (0.110 mmol), Zn(OTf)2 (x mol%), and solvent (0.05 M) 
at 25 °C. Isolated yield after flash chromatography is given. b) No conversion: starting materials 




2.3 Preparation of PyrroleBX and IndoleBX Reagents. 
General Procedure GP2 for the Synthesis of Heterocyclic-BX Reagents 
 
Note: prior to the reaction, the glassware requires to be carefully cleaned with aqua regia to 
remove all metal traces; the commercially available heterocyclic starting material were purified 
through a short plug of silica prior to being used. Compound 5 can be prepared or purchased from 
commercial suppliers. Slow decomposition of 5 is observed at room temperature; for this reason, 
compound 5 should be stored at 3-5 °C and best results are obtained if it is prepared freshly. 
 
In an open air flask, the corresponding heterocycle (1.00 mmol, 1.00 equiv.), 1-acetoxy-1,2-
benziodoxol-3-(1H)-one 5 (337 mg, 1.10 mmol, 1.10 equiv.) and zinc(II) 
trifluoromethanesulfonate (72.7 mg, 0.200 mmol, 20 mol%.) were dissolved in DCM (20 mL 0.05 
M). The reaction was stirred while being monitored by TLC (Pentane:EtOAc 9:1 for the starting 
materials, DCM:MeOH 9:1 for the products). Upon consumption of the starting material, the crude 
was directly submitted to short-path flash chromatography (DCM:MeOH 10:1 or EtOAc:MeOH 
10:1 for the separation of pyrrole-based reagents) to afford the desired Heterocyclic-BX 
compounds 9a-9r.The structure of compounds 9b and 9n was confirmed by X-Ray analysis (see 
par. 5 of the Supplementary Informations). 
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1-(3-1-Methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9a)  
The synthesis of 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9a was scaled up to 10 mmol without reoptimization of the protocol. 
Starting from commercially available 1-methyl-1-H-indole 8a (1.35 g, 10.0 
mmol), after 16 hours 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9a (3.28 g, 8.70 mmol, 87% yield) was obtained as a brown 
foam. Rf: 0.4 (DCM:MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.40 (dd, J = 7.5, 1.7 Hz, 1H, 
ArH), 7.82 (s, 1H, NCHCI), 7.55 – 7.48 (m, 2H, ArH), 7.39 – 7.35 (m, 2H, ArH), 7.34 – 7.23 (m, 
2H, ArH + CDCl3), 6.84 (d, J = 8.3 Hz, 1H, ArH), 4.02 (s, 3H, NCH3). 13C NMR (101 MHz, 
CDCl3) δ 166.8, 138.6, 137.6, 133.4, 133.3, 132.5, 130.5, 129.3, 125.2, 124.3, 122.6, 119.9, 116.1, 
110.7, 78.9, 33.9. IR ν 3107 (w), 3059 (w), 2948 (w), 1599 (s), 1552 (m), 1506 (m), 1454 (w), 
1392 (m), 1277 (s), 1245 (s), 1225 (s), 1166 (s), 1131 (m), 1031 (s), 1004 (w), 842 (w). HRMS 
(ESI) calcd for C16H13INO2+ [M+H]+ 377.9986; found 377.9990. The structure of the obtained 
regioisomer was assigned by NMR correlation to  compound 9b. DSC-analysis was performed on 
compound 9a: see par.5 of Supplementary informations. 
 
1-(3-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9b) 
Starting from 1-(tert-butyldimethylsilyl)-1H-indole 36 (231 mg, 1.00 mmol) 
and using Sc(OTf)3 as the Lewis acid (20 mol %), after 16 hours 1-(3-1H-
indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9b (294 mg, 8.10 mmol, 78% 
yield) was obtained as a brown solid. Rf: 0.4 (DCM:MeOH 9:1). Mp: 
174.2°C (decomposition) 1H NMR (400 MHz, DMSO-d6) δ 12.33 (s, 1H, 
NH), 8.21 (s, 1H, NCHCI), 8.08 (dd, J = 7.3, 1.7 Hz, 1H, ArH), 7.59 (d, J = 8.2 Hz, 1H, ArH), 7.52 
(t, J = 7.3 Hz, 1H, ArH), 7.43 (d, J = 7.5 Hz, 1H, ArH), 7.36 (ddd, J = 8.5, 7.3, 1.7 Hz, 1H, ArH), 
7.26 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H, ArH), 7.15 (t, J = 7.5 Hz, 1H, ArH), 6.72 (d, J = 8.5 Hz, 1H, 
ArH). 13C NMR (101 MHz, DMSO-d6) δ 166.1, 136.6, 134.5, 133.3, 131.4, 130.2, 128.5, 126.3, 
123.4, 122.3, 121.6, 119.2, 116.1, 112.9, 80.0. IR ν 3302 (w), 2975 (w), 2903 (w), 1722 (w), 1609 
(m), 1584 (m), 1557 (w), 1490 (w), 1457 (w), 1385 (w), 1277 (s), 1258 (s), 1230 (m), 1174 (m), 
1087 (w), 1036 (s), 880 (w), 841 (w). HRMS (ESI) calcd for C15H11INO2+ [M+H]+ 363.9829; 
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found 363.9832. The structure of the reagent was determined through X-Ray diffraction of a single 
crystal (CCDC number: 1540821). 
 
1-(3-1-(But-3-en-1-yl)-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9c) 
Starting from 1-(but-3-en-1-yl)-1H-indole 37 (171 mg, 1.00 mmol), 
after 16 hours 1-(3-1-(but-3-en-1-yl)-1H-indole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9c (359 mg, 0.860 mmol, 86% yield) was 
obtained, as a yellow amorphous solid. Rf: 0.44 (DCM:MeOH 9:1). 
1H NMR (400 MHz, CDCl3) δ 8.35 (dd, J = 7.4, 1.7 Hz, 1H, ArH), 
7.91 (s, 1H, NCHCI), 7.54 (m, 1H, ArH), 7.49 (td, J = 7.3, 0.9 Hz, 1H, ArH), 7.46 – 7.39 (m, 2H, 
ArH), 7.32 – 7.19 (m, 2H, ArH), 6.73 (dd, J = 8.3, 0.9 Hz, 1H, ArH), 5.82 (ddt, J = 17.1, 10.3, 6.9 
Hz, 1H, NCH2CH2CH=CH2), 5.12 – 4.97 (m, 2H, NCH2CH2CH=CH2), 4.41 (t, J = 6.9 Hz, 2H, 
NCH2), 2.71 (m, 2H, CH2). 13C NMR (101 MHz, CDCl3) δ 166.8, 137.9, 136.7, 133.6, 133.4, 
133.2, 132.5, 130.5, 129.4, 125.2, 124.2, 122.5, 120.0, 118.6, 116.2, 110.9, 79.0, 46.9, 34.2. IR ν 
3082 (w), 1607 (s), 1557 (m), 1500 (m), 1456 (w), 1437 (w), 1389 (w), 1358 (m), 1262 (w), 1160 
(w), 1005 (w), 919 (w), 830 (w). HRMS (ESI) calcd for C19H17INO2+ [M+H]+ 418.0299; found 
418.0294. The structure of the obtained regioisomer was assigned by NMR correlation to 
compound 9b. 
 
1-(3-1-(2-((Triisopropylsilyl)oxy)ethyl)-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9d) 
Starting from 1-(2-((triisopropylsilyl)oxy)ethyl)-1H-indole 40 
(318 mg, 1.00 mmol), after 16 hours 1-(3-1-(2-
((triisopropylsilyl)oxy)ethyl)-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9d (873 mg, 0.929 mmol, 60% yield) was obtained as 
an orange oil. Rf: 0.40 (DCM:MeOH 9:1). 1H NMR (400 MHz, 
CDCl3) δ 8.47 (d, J = 7.5 Hz, 1H, ArH), 7.99 (s, 1H, NCHCI), 7.65 (d, J = 8.5 Hz, 1H, ArH), 7.59 
(t, J = 7.5 Hz, 1H, ArH), 7.51 – 7.45 (m, 2H, ArH), 7.35 (m, 2H, ArH), 6.94 (d, J = 8.3 Hz, 1H, 
ArH), 4.54 (t, J = 5.0 Hz, 2H, CH2), 4.20 (t, J = 5.0 Hz, 2H, CH2), 1.09 (dd, J = 8.7, 5.6 Hz, 3H, 
SiCH(CH3)2), 1.01 (d, J = 7.1 Hz, 18H, SiCH(CH3)2). 13C NMR (101 MHz, CDCl3) δ 167.0, 138.8, 
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137.1, 133.2, 133.2, 132.4, 130.4, 129.1, 125.3, 124.0, 122.4, 119.7, 115.8, 111.0, 78.3, 62.3, 49.8, 
17.7, 11.6. IR ν 2942 (w), 2890 (w), 2865 (m), 1716 (w), 1604 (s), 1555 (w), 1500 (w), 1458 (w), 
1358 (m), 1249 (m), 1169 (w), 1115 (w), 1015 (w), 883 (m), 831 (m). HRMS (ESI) calcd for 
C26H35INO3Si+ [M+H]+ 564.1425; found 564.1431. The structure of the obtained regioisomer was 
assigned by NMR correlation to compound 9b. 
 
1-(3-1-(3-Phenylpropyl)-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9e) 
Starting from 1-(3-phenylpropyl)--indole 41 (235 mg, 1.00 mmol), 
after 16 hours 1-(3-1-(3-phenylpropyl)-1H-indole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9e (436 mg, 0.906 mmol, 91% yield) was 
obtained as an orange resin. Rf: 0.45 (DCM:MeOH 9:1). 1H NMR 
(400 MHz, CDCl3) δ 8.37 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 7.86 (s, 
1H, NCHCI), 7.54 – 7.36 (m, 4H, ArH), 7.33 – 7.19 (m, 5H, ArH), 7.18 – 7.14 (m, 2H, ArH), 6.79 
(dd, J = 8.3, 0.8 Hz, 1H, ArH), 4.34 (t, J = 7.2 Hz, 2H, NCH2), 2.73 (t, J = 7.5 Hz, 2H, CH2Ph), 
2.35 (m, 2H, CH2-CH2-CH2). 13C NMR (101 MHz, CDCl3) δ 166.8, 140.0, 137.8, 136.8, 133.4, 
133.2, 132.4, 130.4, 129.3, 128.6, 128.3, 126.4, 125.2, 124.1, 122.5, 120.0, 116.1, 110.9, 78.9, 
46.7, 32.8, 31.1. IR ν 3060 (w), 3026 (w), 2939 (w), 1717 (w), 1601 (s), 1551 (m), 1498 (m), 1455 
(w), 1364 (w), 1245 (w), 1165 (w), 1005 (w), 828 (m). HRMS (ESI) calcd for 
C24H21INO2+ [M+H]+ 482.0612; found 482.0614. The structure of the obtained regioisomer was 
assigned by NMR correlation to compound 9b. 
 
1-(3-1,2-Dimethyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9f) 
Starting from 2-methyl-1-methyl-1H-indole 28 (145 mg, 1.00 mmol), after 
16 hours 1-(3-1,2-dimethyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9f (364 mg, 0.930 mmol, 93% yield) was obtained as a dark violet foam. 
Rf: 0.43 (DCM:MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.42 (dd, J = 
7.3, 1.7 Hz, 1H, ArH), 7.52 (td, J = 7.3, 0.9 Hz, 1H, ArH), 7.44 (d, J = 8.2 
Hz, 1H, ArH), 7.35 (m, 2H, ArH), 7.28 (m, 1H, ArH), 7.23 (ddd, J = 8.2, 6.9, 1.0 Hz, 1H, ArH), 
6.77 (m, 1H, ArH), 3.91 (s, 3H, CH3N), 2.65 (s, 3H, ICH=CHCH3). 13C NMR (101 MHz, CDCl3) 
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δ 166.8, 145.3, 137.9, 133.7, 133.2, 132.7, 130.5, 128.9, 124.7, 123.6, 122.4, 119.2, 115.5, 110.4, 
80.1, 31.1, 13.2. IR ν 3055 (w), 2987 (w), 2948 (w), 1717 (w), 1605 (s), 1584 (m), 1553 (m), 1516 
(w), 1472 (w), 1437 (w), 1395 (m), 1378 (m), 1268 (m), 1154 (w), 1032 (w), 1011 (w), 829 (w). 
HRMS (ESI) calcd for C17H15INO2+ [M+H]+ 392.0142; found 392.0146. The structure of the 
obtained regioisomer was assigned by NMR correlation to compound 9b. 
 
1-(3-5-Methoxy-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9g) 
Starting from 5-methoxy-1-methyl- 1H-indole 29 (161 mg, 1.00 mmol), 
after 16 hours 1-(3-5-methoxy-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9g (346 mg, 0.850 mmol, 85% yield) was obtained as an orange 
resin. Rf: 0.42 (DCM:MeOH 9:1). NB: the reagent was isolated in 
presence of a small amount of the polymerized form of the heterocycles 
(4% of estimated impurity).  1H NMR (400 MHz, CDCl3) δ 8.35 (dd, J = 7.5, 1.6 Hz, 1H, ArH), 
7.82 (s, 1H, NCHCI), 7.48 (t, J = 7.3 Hz, 1H, ArH), 7.40 (d, J = 9.0 Hz, 1H, ArH), 7.27 (m, 1H, 
ArH), 7.04 (dd, J = 9.0, 2.4 Hz, 1H, ArH), 6.84 (d, J = 8.3 Hz, 1H, ArH), 6.79 (d, J = 2.3 Hz, 1H, 
ArH), 3.99 (s, 3H, CH3N), 3.78 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3) δ 167.1, 156.4, 138.9, 
133.3, 132.5, 132.5, 130.5, 130.1, 125.2, 116.0, 114.8, 111.7, 100.8, 77.4, 55.8, 34.0 (the signal for 
one aromatic C could not be resolved). IR ν 3110 (w), 3062 (w), 3000 (w), 2944 (w), 2837 (w), 
1719 (w), 1604 (m), 1584 (m), 1556 (w), 1504 (m), 1489 (m), 1439 (w), 1378 (w), 1249 (s), 1223 
(s), 1158 (m), 1031 (s), 970 (w), 845 (m). HRMS (ESI) calcd for C17H15INO3+ [M+H]+ 408.0091; 
found 408.0093. The structure of the obtained regioisomer was assigned by NMR correlation to 
compound 9b. 
 
1-(3-5-Fluoro-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9h) 
Starting from 5-fluoro-1-methyl-1H-indole 30 (149 mg, 1.00 mmol), after 
16 hours 1-(3-5-fluoro-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9h (336 mg, 0.850 mmol, 85% yield) was obtained as an yellow foam. 
Rf: 0.3 (DCM:MeOH 9:1). NB: the reagent was isolated in presence of a 
small amount of the polymerized form of the heterocycles (7% of 
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estimated impurity).  1H NMR (400 MHz, CD3OD) δ 8.1 (dd, J = 7.6, 1.7 Hz, 1H, ArH), 8.01 (s, 
1H, NCHCI), 7.57 (ddd, J = 8.8, 4.2, 0.8 Hz, 1H, ArH), 7.49 (td, J = 7.4, 1.0 Hz, 1H, ArH), 7.30 
(ddd, J = 8.3, 7.2, 1.7 Hz, 1H, ArH), 7.14 – 7.03 (m, 2H, ArH), 6.80 (dd, J = 8.3, 0.9 Hz, 1H, ArH), 
3.93 (s, 3H, CH3N). 13C NMR (101 MHz, CD3OD) δ 170.3, 160.91 (d, J = 238.2 Hz), 142.6, 135.9, 
135.1, 134.4, 133.2, 131.7, 131.40 (d, J = 10.7 Hz), 127.7, 116.8, 113.71 (d, J = 9.8 Hz), 113.47 
(d, J = 26.7 Hz), 105.67 (d, J = 25.3 Hz), 77.5, 34.3. 19F NMR (376 MHz, CDCl3) δ -119.8.  IR ν 
3083 (w), 2952 (w), 1717 (w), 1601 (s), 1557 (m), 1503 (m), 1485 (m), 1438 (w), 1338 (m), 1242 
(m), 1193 (m), 1121 (m), 1032 (w), 1005 (w), 850 (m). HRMS (ESI) calcd for 
C16H12FINO2+ [M+H]+ 395.9891; found 395.9894. The structure of the obtained regioisomer was 
assigned by NMR correlation to compound 9b. 
 
1-(3-5-Chloro-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9i) 
Starting from 5-chloro-1-methyl-1H-indole 31 (166 mg, 1.00 mmol), after 
16 hours 1-(3-5-chloro-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9i (256 mg, 0.622 mmol, 62% yield) was obtained as an orange 
amorphous solid. Rf: 0.4 (DCM:MeOH 9:1). 1H NMR (400 MHz, CD2Cl2) 
δ 8.20 (d, J = 7.4 Hz, 1H, ArH), 7.78 (s, 1H, NCHCI), 7.38 (d, J = 8.7 Hz, 
1H, ArH), 7.34 – 7.22 (m, 3H, ArH), 7.17 (t, J = 7.7 Hz, 1H, ArH), 6.68 (d, J = 8.2 Hz, 1H, ArH), 
3.87 (s, 3H, CH3NCHCI). 13C NMR (101 MHz, CD3OD) δ 170.3, 142.5, 137.8, 135.1, 134.4, 
133.2, 131.7, 131.7, 129.6, 127.8, 125.4, 120.0, 116.8, 113.7, 77.5, 34.2. IR ν 3095 (w), 2953 (w), 
1605 (s), 1556 (m), 1505 (m), 1438 (m), 1388 (m), 1370 (m), 1260 (s), 1226 (m), 1164 (m), 1144 
(m), 1115 (w), 1070 (w), 1032 (s), 1004 (w), 837 (w). HRMS (ESI) calcd for 
C16H12ClINO2+ [M+H]+ 411.9596; found 411.9603. The structure of the obtained regioisomer was 
assigned by NMR correlation to compound 9b. 
 
1-(3-5-Iodo-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9j) 
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Starting from 5-iodo-1-methyl-1H-indole 32 (257 mg, 1.00 mmol), after 16 
hours 1-(3-5-iodo-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9j (380 mg, 0.755 mmol, 76% yield) was obtained as a yellow amorphous 
solid. Rf: 0.3 (DCM:MeOH 9:1). NB: the reagent is unstable in acidic 
deuterated solvents and it decompose in short time, we recommend the 
immediate use after the synthesis. The proton NMR presents about 21% of the open protonated 
form. 1H NMR (400 MHz, CDCl3) δ 8.24 (m, 1H, ArH), 7.83 (s, 1H, NCHCI), 7.58 – 7.47 (m, 2H, 
ArH), 7.26 (m, 1H, ArH + CDCl3 ), 7.21 - 7.18 (m, 2H, ArH), 6.67 (d, J = 8.1 Hz, 1H, ArH), 3.87 
(s, 3H, CH3N). 13C NMR (101 MHz, CDCl3) δ 168.6, 140.5, 136.8, 133.7, 132.6, 132.3, 131.4, 
130.3, 128.1, 126.0, 122.3, 119.1, 115.7, 112.9, 86.1, 34.0. IR ν 3092 (w), 3061 (w), 1600 (s), 1584 
(m), 1557 (m), 1503 (m), 1436 (w), 1422 (w), 1371 (m), 1265 (s), 1245 (s), 1225 (m), 1163 (m), 
1113 (w), 1031 (s), 1004 (w), 836 (w). HRMS (ESI) calcd for C16H12I2NO2+ [M+H]+ 503.8952; 





Starting from commercially available 1-methyl-5-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-1H-indole (149 mg, 1.00 mmol), after 16 hours 1-
(3-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole)-
1H-1λ3 -benzo[b]iodo-3(2H)-one 9k (276 mg, 0.549 mmol, 54% yield) was 
obtained as an orange amorphous solid. Rf: 0.46 (DCM:MeOH 9:1). 1H 
NMR (400 MHz, CD2Cl2) δ 8.32 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 7.93 (s, 1H, NCHCI), 7.81 (dd, J 
= 8.4, 1.1 Hz, 1H, ArH), 7.74 (s, 1H, CCHCBPin), 7.59 – 7.48 (m, 2H, ArH), 7.31 (ddd, J = 8.6, 
7.1, 1.7 Hz, 1H, ArH), 6.85 (dd, J = 8.3, 0.9 Hz, 1H, ArH), 3.99 (s, 3H, CH3N), 1.30 (s, 12H, 
CBPin). 13C NMR (101 MHz, CD2Cl2) δ 167.0, 140.1, 139.6, 134.1, 133.8, 132.6, 131.0, 130.5, 
129.5, 127.6, 126.0, 117.1, 110.7, 84.5, 80.3, 34.4, 25.2 (one aromatic Carbon signal not resolved). 
IR ν 3095 (w), 2979 (w), 1611 (s), 1558 (w), 1507 (w), 1436 (w), 1360 (s), 1303 (w), 1263 (w), 
1142 (s), 1114 (w), 1074 (w), 970 (w), 861 (w). HRMS (ESI) calcd for 
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C22H24BINO4+ [M+H]+ 504.0838; found 504.0835. The structure of the obtained regioisomer was 
assigned by NMR correlation to compound 9b. 
1-(3-1-Methyl-1H-pyrrolo[2,3-b]pyridine)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9l) 
Starting from commercially available 1-methyl-1H-pyrrolo[2,3-b]pyridine 
(132 mg, 1.00 mmol), after 16 hours 1-(3-1-methyl-1H-pyrrolo[2,3-
b]pyridine)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9l (114 mg, 0.301 mmol, 30% 
yield) was obtained as a brown amorphous solid. Rf: 0.2 (DCM:MeOH 9:1). 
1H NMR (400 MHz, CD2Cl2) δ 8.37 (dd, J = 4.7, 1.6 Hz, 1H, ArH), 8.06 
(dd, J = 7.9, 1.2 Hz, 1H, ArH), 7.96 (dd, J = 7.9, 1.7 Hz, 1H, ArH), 7.92 (dd, J = 7.9, 1.7 Hz, 1H, 
ArH), 7.46 (td, J = 7.7, 1.2 Hz, 1H, ArH), 7.25 – 7.19 (m, 2H, ArH), 7.14 (dd, J = 7.9, 4.7 Hz, 1H, 
ArH), 3.86 (s, 3H, CH3N). 13C NMR (101 MHz, CD2Cl2) δ 168.6, 144.4, 142.3, 134.3, 133.8, 
132.1, 128.7, 127.0, 126.3, 118.8, 116.5, 103.2, 94.9, 31.7 (one Carbon signal not resolved). IR ν 
2925 (w), 2852 (w), 1719 (s), 1599 (m), 1585 (m), 1468 (m), 1408 (w), 1348 (w), 1289 (m), 1262 
(s), 1136 (m), 1103 (w), 1042 (w), 1017 (m), 976 (w). HRMS (ESI) calcd for 
C15H12IN2O2+ [M+H]+ 378.9938; found 378.9945. The structure of the obtained regioisomer was 
assigned by NMR correlation to compound 9b. 
 
1-(3-1H-Pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9m) 
Starting from 1-(tert-butyldimethylsilyl)-1H-pyrrole 35 (181 mg, 1.00 mmol) 
and using Sc(OTf)3 as the Lewis Acid (20 mol%), after 16 hours 1-(3-1H-
pyrrole)- 1H-1λ3 -benzo[b]iodo-3(2H)-one 9m (225 mg, 0.719 mmol, 72% 
yield) was obtained  as a slightly brown solid. Rf: 0.5 (DCM:MeOH 9:1). Mp: 
147°C (decomposition). 1H NMR (400 MHz, CD3OD) δ 8.40 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 7.72 
(d, J = 7.4 Hz, 1H, ArH), 7.68 – 7.59 (m, 2H, ArH), 7.23 (t, J = 2.4 Hz, 1H, ArH), 7.14 (d, J = 8.2 
Hz, 1H, ArH), 6.74 (dd, J = 2.8, 1.5 Hz, 1H, ArH) (NH signal exchanges with CD3OD). 13C NMR 
(101 MHz, CD3OD) δ 170.3, 135.0, 134.4, 132.9, 131.5, 130.4, 128.0, 123.7, 117.3, 115.9, 83.4. 
IR ν 3484 (w), 1607 (w), 1558 (w), 1439 (w), 1397 (w), 1260 (s), 1236 (s), 1174 (s), 1084 (w), 
1050 (m), 1038 (m), 903 (w), 882 (w). HRMS (ESI) calcd for C11H9INO2+ [M+H]+ 313.9673; 





1-(3-1-Methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9n) and 1-(2-1-methyl-1H-
pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9o) 
Starting from commercially available 1-methyl-1H-
pyrrole (0.890 ml, 1.00 mmol), after 12 hours 1-(3-1-
methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9n and 1-(2-1-methyl-1H-pyrrole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9o were obtained as a 1:1 
mixture (overall yield 95%) as an off-white, sticky amorphous solid. Rf: 0.5 (DCM:MeOH 9:1). 
The two compounds were separated by slow flash column chromatography (EtOAc:MeOH 9:1). 
The structure of the obtained regioisomers were assigned by NMR correlation to compound 9m.  
 
1-(3-1-methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9n (158 mg, 
0.483 mmol, 48% yield; off-white, sticky amorphous solid). Rf: 0.25 
(EtOAc:MeOH 9:1). 1H NMR (400 MHz, CD3OD) δ 8.15 (dd, J = 7.5, 1.7 
Hz, 1H, ArH), 7.53 (td, J = 7.3, 1.1 Hz, 1H, ArH), 7.49 – 7.40 (m, 2H, ArH), 
7.04 – 6.98 (m, 2H, ArH), 6.58 (d, J = 1.2 Hz, 1H, ArH), 3.85 (s, 3H, NMe). 
13C NMR (101 MHz, CD3OD) δ 170.0, 134.9, 134.2, 133.4, 132.8, 131.5, 127.9, 127.7, 117.4, 
116.6, 82.8, 37.1. IR ν 3447 (w), 3106 (w), 2947 (w), 2863 (w), 1603 (s), 1591 (m), 1558 (m), 
1512 (m), 1437 (w), 1354 (m), 1294 (w), 1110 (m), 1083 (w), 1007 (w), 829 (m). HRMS (ESI) 
calcd for C12H11INO2+ [M+H]+ 327.9829; found 327.9831. DSC-analysis was performed on 
compound 9n: see par.5 of Supplementary informations. 
 
1-(2-1-methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9o (152 mg, 
0.465 mmol, 47% yield; off-white, sticky amorphous solid) Rf: 0.3 
(EtOAc:MeOH 9:1). 1H NMR (400 MHz, CD3OD) δ 8.24 (dd, J = 7.5, 1.6 Hz, 
1H, ArH), 7.65 (td, J = 7.4, 1.0 Hz, 1H, ArH), 7.55 (m, 1H, ArH), 7.27 (t, J = 
2.1 Hz, 1H, ArH), 7.01 (dd, J = 3.9, 1.6 Hz, 1H, ArH), 6.72 (dd, J = 8.3, 1.0 
Hz, 1H, ArH), 6.43 (dd, J = 3.9, 2.1 Hz, 1H, ArH), 3.78 (s, 1H, NCH3). 13C NMR (101 MHz, 
CD3OD) δ 170.1, 135.5, 134.2, 133.2, 131.9, 131.4, 127.7, 126.6, 119.4, 112.9, 96.0, 37.4. IR ν 
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3415 (w), 3105 (w), 3049 (w), 2950 (w), 1604 (s), 1584 (m), 1558 (w), 1508 (w), 1437 (w), 1346 
(m), 1288 (m), 1223 (w), 1149 (w), 1091 (w), 1047 (w), 1005 (w), 829 (m). HRMS (ESI) calcd 
for C12H11INO2+ [M+H]+ 327.9829; found 327.9842. DSC-analysis was performed on compound 
9o: see par.5 of Supplementary informations. 
 
1-(3-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9p) and 1-(2-1-benzyl-1H-
pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9q) 
Starting from commercially available 1-methyl-
1H-pyrrole (0.890 ml, 1.00 mmol), after 12 hours 
1-(3-1-benzyl-1H-pyrrole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9p and 1-(2-1-benzyl-
1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9q 
were obtained in 3:1 mixture (overall yield 86%), 
as a colorless amorphous solid. Rf: 0.7 
(DCM:MeOH 9:1). The two compounds were separated by slow flash column chromatography 
(EtOAc:MeOH 9:1). The structure of the obtained regioisomers were assigned by NMR correlation 
to compound 9m. 
 
1-(3-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9p (260 
mg, 0.645 mmol, 65% yield) as a colorless foam. Rf: 0.46 
(EtOAc:MeOH 9:1). 1H NMR (400 MHz, 2:1 mixture CD3OD:C6D6, 
refered to CD3OD) δ 8.29 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 7.36 (t, J = 
7.3 Hz, 1H, ArH), 7.30 – 7.20 (m, 3H ArH + C6D6), 7.18 – 7.08 (m, 
3H, ArH), 6.97 (d, J = 2.0 Hz, 1H, ArH), 6.83 – 6.78 (m, 2H, ArH), 
6.30 (dd, J = 3.0, 1.7 Hz, 1H, ArH), 4.93 (s, 2H, NCH2Ph). 13C NMR (101 MHz, 2:1 mixture 
CD3OD:C6D6, refered to CD3OD) δ 168.7, 136.8, 133.5, 133.0, 131.8, 130.9, 130.3, 128.8, 128.1, 
127.4, 126.2, 125.5, 116.3, 115.3, 82.4, 53.5. IR ν 3409 (w), 3114 (w), 2971 (w), 1609 (s), 1585 
(m), 1558 (w), 1456 (w), 1438 (w), 1365 (m), 1277 (s), 1160 (w), 1079 (w), 1032 (m), 835 (w). 





1-(2-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9q (85.0 mg, 
0.211 mmol, 21% yield) as a colorless foam. Rf: 0.5 (EtOAc:MeOH 9:1). 1H 
NMR (400 MHz, 2:1 mixture CD3OD:C6D6, referered to CD3OD) δ 8.18 (dd, 
J = 7.5, 1.6 Hz, 1H, ArH), 7.28 (t, J = 7.4 Hz, 1H, ArH), 7.10 (t, J = 2.2 Hz, 
1H, ArH), 6.92 (m, J = 7.6, 2.9 Hz, 6H, ArH + C6D6), 6.71 (dd, J = 3.9, 1.7 
Hz, 1H, ArH), 6.35 (t, J = 3.4 Hz, 1H, ArH), 6.23 (d, J = 8.3 Hz, 1H, ArH), 
4.90 (s, 2H, NCH2Ph). 13C NMR (101 MHz, 2:1 mixture CD3OD:C6D6, referered to CD3OD) δ 
169.8, 136.9, 134.6, 132.7, 131.2, 131.1, 129.5, 129.0, 128.5, 127.2, 119.2, 112.9, 94.8, 54.7 (two 
Carbon signals under the deuterated benzene). IR ν 3109 (w), 3064 (w), 2968 (w), 2875 (w), 1609 
(s), 1585 (m), 1558 (w), 1503 (w), 1456 (w), 1440 (w), 1357 (m), 1277 (w), 1103 (m), 1079 (w), 
1032 (w), 1031 (w), 830 (w). HRMS (ESI) calcd for C18H15INO2+ [M+H]+ 404.0142; found 
404.0140. 
 
1-(3-9-Methyl-9H-carbazole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9r) 
Starting from commercially available 9-methyl-9H-carbazole (181 mg, 
1.00 mmol), after 16 hours 1-(3-9-methyl-9H-carbazole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9r (110 mg, 0.257 mmol, 33% yield) was 
obtained as a grey amorphous solid. Rf: 0.2 (DCM:MeOH 9:1). 1H 
NMR (400 MHz, CDCl3) δ 8.67 (d,  J = 1.6 Hz, 1H, ArH), 8.47 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 
8.14 (d, J = 7.9 Hz, 1H, ArH), 7.96 (dd,  J = 8.5, 1.6 Hz, 1H, ArH), 7.63 (ddd, J = 8.4, 7.1, 1.2 Hz, 
1H, ArH), 7.59 (d, J = 8.5 Hz, 1H, ArH), 7.57 – 7.52 (m, 2H, ArH), 7.37 (td, J = 7.5, 1.2 Hz, 1H, 
ArH), 7.30 (ddd, J = 8.5, 7.1, 1.7 Hz, 1H, ArH), 6.69 (dd, J = 8.5, 0.9 Hz, 1H, ArH), 3.98 (s, 3H, 
NCH3). 13C NMR (101 MHz, CDCl3) δ 166.5, 142.4, 141.4, 133.4, 133.3, 132.7, 130.6, 130.0, 
127.7, 125.8, 125.7, 121.4, 120.8, 120.7, 116.3, 112.0, 109.3, 101.8, 53.4, 29.5. IR ν 3082 (w), 
2974 (w), 2924 (w), 2816 (w), 1652 (s), 1588 (w), 1570 (w), 1456 (w), 1440 (m), 1295 (m), 1245 
(w), 1139 (w), 1017 (w), 982 (m), 831 (w). HRMS (ESI) calcd for C20H15INO2+ [M+H]+ 428.0142; 
found 428.0147. 
1-(2-1H-Thiophene)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9s) 
S27 
 
Starting from commercially available thiophene (80.0 µL, 1.00 mmol) and 
using Sc(OTf)3 as the Lewis Acid (20 mol%), after 16 hours 1-(2-1H-
thiophene)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9s) (102 mg, 0.309 mmol, 31% 
yield) was obtained  as a light yellow amorphous solid. Rf: 0.4 (DCM:MeOH 
9:1). NB: the reagent is unstable in protic deuterated solvents and it decompose in short time, 
we recommend the immediate use after the synthesis. The proton NMR presents about 7% of the 
open protonated form. 1H NMR 1H NMR (400 MHz, CD3OD) δ 8.28 (dd, J = 7.5, 1.7 Hz, 1H, 
ArH), 8.05 (dd, J = 5.2, 1.2 Hz, 1H, ArH), 7.98 (dd, J = 3.7, 1.2 Hz, 1H, ArH), 7.70 (td, J = 7.4, 
0.9 Hz, 1H, ArH), 7.61 (ddd, J = 8.7, 7.2, 1.7 Hz, 1H, ArH), 7.37 (dd, J = 5.3, 3.6 Hz, 1H, ArH), 
6.92 (dd, J = 8.3, 0.9 Hz, 1H, ArH). 13C NMR (101 MHz, CDCl3) δ 166.6, 141.5, 137.1, 134.1, 
132.7, 131.0, 130.4, 125.2, 117.8, 104.2 (one aromatic Carbon signal not resolved). IR ν 3080 (w), 
2958 (w), 2925 (m), 2853 (w), 1716 (w), 1622 (s), 1603 (s), 1558 (m), 1438 (w), 1354 (w), 1341 
(w), 1299 (w), 1223 (w), 1006 (w), 951 (w), 834 (w), 830 (w). HRMS (ESI) calcd for 
C11H8IO2S+ [M+H]+ 330.9284; found 330.9291. 
 
1-(3-1H-2,5-dimethylfuran)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9t) 
Starting from commercially available 2,5-dimethylfuran (107 µL, 1.00 
mmol) and using In(OTf)3 as the Lewis Acid (20 mol%), after 24 hours 1-
(3-1H-2,5-dimethylfuran)-1H-1λ3 -benzo[b]iodo-3(2H)-one (9t) (47.0 mg, 
0.137 mmol, 14% yield) was obtained  as a brown resin. Rf: 0.3 
(DCM:MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.28 (dd, J = 7.4, 1.8 Hz, 
1H, ArH), 7.50 (t, J = 7.3 Hz, 1H, ArH), 7.43 (td, J = 7.7, 7.3, 1.8 Hz, 1H, ArH), 7.00 (d, J = 8.1 
Hz, 1H, ArH), 6.21 (s, 1H, ArH), 2.42 (s, 3H, FuraneCH3), 2.31 (s, 3H, FuraneCH3). 13C NMR 
(101 MHz, CDCl3) δ 166.9, 158.9, 154.2, 133.5, 133.1, 132.4, 130.4, 125.4, 115.0, 110.4, 88.0, 
13.4, 13.2. IR ν 3430 (w), 3111 (w), 3065 (w), 2923 (w), 2854 (w), 1607 (s), 1559 (m), 1438 (m), 
1348 (m), 1298 (w), 1229 (w), 1128 (w), 1039 (w), 1007 (w), 926 (w), 831 (m). HRMS (ESI) calcd 




2.3 Preparation of β-Phenyliodonioindole Tetrafluoroborate (18). 
 
Following a reported procedure,13 to a stirred solution of fine crushed KOH (5.61 g, 100 mmol, 
5.00 equiv.) in MeOH (20.0 mL, 1.0 M), 1H-indole 34 (2.34 g, 20.0 mmol, 1.00 equiv.) was added 
in portions at 0 °C. The resulting mixture was left stirring at 0 °C until complete dissolution of the 
1H-indole (1.5 h). Then PIDA (6.44 g, 20.0 mmol, 1.00 equiv.) was added portionwise and the 
reaction mixture left stirring at 0 °C for 1.5 h. Betaine I intermediate (dark yellow green solid in 
suspension) was then removed by filtration over a glass-synthered funnel, washed with cold MeOH 
and CHCl3 and air dried in the dark at 0 °C. Betaine I intermediate (2.20 g, 6.89 mmol, 35% yield) 
was obtained as a dark yellow green amorphous solid. 
Caution: Betaine I is a highly unstable intermediate, it is reported to detonate at room 
temperature; do NOT grind it, it may explode. The Betaine I intermediate decomposes at -20 °C, 
it is recommended to be used immediately after its preparation. 
HBF4 (450 µL, 6.89 mmol, 1.00 equiv., 48 wt.% solution in H2O) was added to EtOH (10 mL) and 
the resulting solution cooled at -15 °C; then Betaine I intermediate (2.20 g, 6.89 mmol, 1.00 equiv.) 
was added portionwise under vigorous stirring at -15 °C. After all of Betaine I had been added, the 
dark brown resulting reaction mixture was diluted with Et2O (50 mL) and stirred for 1.5 h at -15 
°C. Then stirring was stopped and the reaction left at -15 °C for 30 min. The resulting precipitate 
was then removed by filtration over a glass-synthered funnel and dried at 0 °C to give β-
Phenyliodonioindole Tetrafluoroborate 18 (2.10 g, 5.16 mmol, 75% yield) as a yellowish green 
amorphous solid.  
                                                 





Caution: β-Phenyliodonioindole Tetrafluoroborate 18 is an unstable salt and it was immediately 
used after its preparation. 
1H NMR (400 MHz, DMSO-d6) δ 12.32 (brs, 1H, NH), 8.40 (d, J = 2.7 Hz, 
1H, ArH), 8.14 – 8.12 (m, 2H, ArH), 7.74 (m, 1H, ArH), 7.58 – 7.55 (m, 2H), 
7.47 – 7.43 (m, 2H), 7.35 – 7.16 (m, 2H). (presence of Et2O residual solvent 
as the NMR analysis was performed on the slightly wet compound to prevent 
decomposition). 13C NMR (101 MHz, DMSO-d6) δ 135.8, 135.1, 134.0, 131.5, 
127.1, 123.6, 121.9, 118.8, 117.3, 113.0, 78.0. (one aromatic Carbon signal not resolved). IR ν 
3375 (s), 3132 (w), 1561 (m), 1491 (m), 1472 (s), 1411 (s), 1340 (m), 1328 (m), 1279 (s), 1244 (s). 





3.1 Synthesis of Starting Materials.  
All commercially available chemicals were purchased from the suppliers quoted in Paragraph 1.0 
of Supplementary Informations: these chemicals were purified through a short plug of celite prior 
to their use in catalysis. The synthesis of non commercial available compounds is presented below. 
 
Methyl 4-(pyridin-2-yl)benzoate (44) 
  
Following a reported procedure,14 to a solution of commercially available 2-bromopyridine 42 (100 
µL, 1.00 mmol) in a mixture of 4/1 toluene/EtOH (5 mL, 0.2 M) was added Na2CO3 (106 mg, 1.00 
mmol, 1.00 equiv.) followed by Pd(PPh3)4  (34.7 mg, 30.0 µmol, 3 mol %) and (4-
(methoxycarbonyl)phenyl)boronic acid 43 (234 mg, 1.30 mmol, 1.30 equiv.) under argon 
atmosphere in a 50 mL two-necked flask.  The reaction mixture was refluxed for 12 h, and then 
cooled to room temperature. To the reaction mixture was added sat. aqueous NH4Cl (15 mL), then 
the mixture was extracted by EtOAc (3x5 ml). The combined organic extracts were dried over 
MgSO4, filtered and and concentrated in vacuo. The resulting crude product was purified by flash 
chromatography (Pentane:EtOAc 4:1) to afford methyl 4-(pyridin-2-yl)benzoate 44 (181 mg, 0.849 
mmol, 85% yield) as a white solid. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 4.7 Hz, 1H, ArH), 
8.06 (d, J = 8.4 Hz, 2H, ArH), 7.98 (d, J = 8.3 Hz, 2H, ArH), 7.73 – 7.63 (m, 2H, ArH), 7.19 (q, J 
= 4.6 Hz, 1H, ArH), 3.85 (s, 3H COOMe). 13C NMR (101 MHz, CDCl3) δ 166.8, 156.1, 149.8, 
143.4, 136.8, 130.3, 130.0, 126.7, 122.8, 120.9, 52.1.IR ν 2944 (w), 2848 (w), 1708 (s), 1606 (w), 
1586 (m), 1466 (w), 1435 (m), 1405 (w), 1319 (w), 1274 (s), 1194 (m), 1183 (m), 1153 (w), 1111 
(s), 1014 (m), 965 (m), 868 (w), 830 (w), 797 (w), 754 (vs), 699 (m). NMR values are in accordance 
with the data reported in literature.15 
                                                 
[14] H. Mizuno, J. Takaya, N. Iwasawa, J. Am. Chem. Soc. 2011, 133, 1251–1253 






Following a reported procedure,16 commercially available 1H-indole 34 (586 mg, 5.00 mmol) was 
dissolved in N,N-dimethylformamide (15.0 mL, 0.3M) and sodium hydride (60% suspension in 
mineral oil, 300 mg, 7.50 mmol, 1.50 equiv.) was added at r.t. and the reaction mixture was stirred 
for one hour. Upon seizing of gas release, commercially available 2-chloropyrimidine 45 (573 mg, 
5.00 mmol, 1.00 equiv.) was added portionwise. The reaction was heated up to 150 °C and stirred 
overnight. After 10 hours the reaction was allowed cooling to r.t. and was then quenched with water 
(20 mL). The majority of the solvent was removed under reduced pressure, then the crude was 
diluted with Et2O (25 mL), the organic layer washed with brine (3x10 mL), dried over MgSO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (Pentane:EtOAc 
4:1) afforded 1-(pyrimidin-2-yl)-1H-indole 46 (926 mg, 4.74 mmol, 95% yield) as a light brown 
oil. 1H NMR (400 MHz, CDCl3) δ  8.94 (d, J = 8.4 Hz, 1H, ArH), 8.75 (d, J = 4.8 Hz, 2H, ArH), 
8.40 (d, J = 3.7 Hz, 1H, ArH), 7.75 (d, J = 7.8 Hz, 1H, ArH), 7.51 – 7.43 (m, 1H, ArH), 7.37 (t, J 
= 7.5 Hz, 1H, ArH), 7.07 (t, J = 4.8 Hz, 1H, ArH), 6.83 (d, J = 3.6 Hz, 1H, ArH). 13C NMR (101 
MHz, CDCl3) δ 157.7, 157.4, 135.1, 131.1, 125.6, 123.4, 121.9, 120.6, 116.2, 115.8, 106.6. IR ν 
3138 (w), 3108 (w), 1575 (s), 1525 (m), 1456 (s), 1309 (m), 1204 (s), 1080 (m), 970 (s), 776 (m), 




                                                 
[16] M. Nishino, K. Hirano, T. Satoh, M. Miura, Angew. Chem. Int. Ed. 2012, 51, 6993–6997. 




Following a reported procedure,18 commercially available (2R,3R,4S,5R)-2-(6-chloro-9H-purin-9-
yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol 47 (573 mg, 2.00 mmol, 1.00 equiv.) was 
suspended in MeCN (12.5 mL, 0.15 M). Then Triethylamine (2.90 mL, 20.0 mmol, 10.0 equiv.) 
and Acetic Anhydride (1.10 mL µl, 12.00 mmol, 6.00 equiv.) were added at 0° C. After stirring for 
1h at room temperature, the mixture was refluxed for 5 hours. The resulting solution was 
evaporated to dryness and EtOAc (30 mL) and water (30 mL) were added. The organic layer was 
separated, dried over Na2SO4, filtered and concentrated under reduced pressure to give a light 
brown oil, which was recrystallized from EtOAc/Ether to give (2R,3R,4R,5R)-2-(acetoxymethyl)-
5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate 48 (693 mg, 1.68 mmol, 84 % yield)  
 
Subsequently, to a solution of (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-chloro-9H-purin-9-
yl)tetrahydrofuran-3,4-diyl diacetate 48 (500 mg, 1.21 mmol) in a mixture of 4/1 toluene (12 mL, 
0.1 M) was added K2CO3 (218 mg, 1.58 mmol, 1.30 equiv.) followed by Pd(PPh3)4  (42.0 mg, 30.0 
µmol, 3 mol %) and phenylboronic acid 49 (192 mg, 1.58 mmol, 1.30 equiv.) under argon 
atmosphere in a 20 mL two-necked flask. The reaction mixture was refluxed for 12 h, and then 
cooled to room temperature. To the reaction mixture was added sat. aqueous NH4Cl (15 mL), then 
the mixture was extracted by EtOAc (3x5 mL). The combined organic extracts were dried over 
MgSO4, filtered and and concentrated in vacuo. The resulting crude product was purified by flash 
chromatography (Pentane:EtOAc 4:1) to afford (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-phenyl-
9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate 50 (523 mg, 1.15 mmol, 95% yield) as a white 
solid. 1H NMR (400 MHz, CDCl3) δ 8.95 (s, 1H, ArH), 8.68 (dd, J = 8.0, 1.8 Hz, ArH), 8.21 (s, 
1H, ArH), 7.52 – 7.43 (m, 3H, ArH), 6.22 (d, J = 5.3 Hz, 1H, CH), 5.95 (t, J = 5.4 Hz, 1H, CH), 
                                                 
[18] M. A. Ali, X. Yao, H. Sun, H. Lu, Org. Lett. 2015, 17, 1513–1516. 
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5.64 (m, 1H, CH), 4.45 – 4.24 (m, 3H, CH + CH2), 2.08 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.00 (s, 
3H, CH3. 13C NMR (101 MHz, CDCl3) δ 169.9, 169.2, 169.0, 154.7, 152.1, 151.6, 142.5, 135.0, 
131.2, 130.7, 129.4, 128.2, 86.1, 79.9, 72.7, 70.2, 62.7, 20.3, 20.1, 20.0. IR ν 2926 (m), 1749 (s), 
1583 (s), 1566 (s), 1439 (m), 1220 (s), 1101 (m), 766 (m), 693 (m). NMR values are in accordance 





3.2 Procedure for Thio-indolization via Lewis-acid activated IndoleBX 
 
Commercially available 3-methoxybenzenethiol 10 (25.0 µL, 0.200 mmol, 1.00 equiv.) was 
dissolved in dry DCM (2.0 mL, 0.1 M) under nitrogen atmosphere. Then IndoleBX 9a (75.0 mg, 
0.200 mmol, 1.00 equiv.) and the reaction left stirring at r.t. overnite. The majority of the solvent 
was removed under reduced pressure, then the crude was diluted with EtOAc (25 mL), the organic 
layer washed with brine (3x10 mL), dried over MgSO4, filtered and concentrated under reduced 
pressure. Flash column chromatography (Pentane:EtOAc 4:1) afforded 3-((3-
methoxyphenyl)thio)-1-methyl-1H-indole 11 (18.1 mg, 67.0 µmol, 34% yield) as a light yellow 
oil. 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 7.9 Hz, 1H, ArH), 7.38 (d, J = 8.1 Hz, 1H, ArH), 
7.34 (s, 1H, ArH), 7.30 (m, 1H, ArH), 7.16 (ddd, J = 7.9, 6.8, 0.9 Hz, 1H, ArH), 7.06 (t, J = 8.0 
Hz, 1H, ArH), 6.71 – 6.63 (m, 2H, ArH), 6.59 (dd, J = 8.1, 2.5 Hz, 1H, ArH), 3.85 (s, 3H, NMe), 
3.68 (s, 3H, OMe). 13C NMR (101 MHz, CDCl3) δ 160.0, 141.4, 137.7, 135.3, 129.7, 129.6, 122.7, 
120.7, 119.9, 118.3, 111.6, 110.3, 109.8, 100.4, 55.4, 33.4. NMR values are in accordance with the 
data reported in literature.19  
                                                 
[19] H. Qi, T. Zhang, K. Wan, M. Luo, J. Org. Chem. 2016, 81, 4262–4268. 
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3.3 Optimization of the Rh-Catalyzed Indolization of Arenes via C-H activation.     
In a vial, 2-phenylpyridine 12 (14.0 µl, 0.100 mmol), 1-(3-1-methyl-1H-indole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9a (1.10 equiv.), the catalyst system (1.25-5 mol%) and the relative 
additive (2.5-20 mol%) were dissolved in the appropriate dry solvent (0.1 M)  under nitrogen. The 
reaction mixture was degassed (freeze-thaw-pump) and then stirred at the reported T in °C 
overnight. The reaction mixture was then allowed to cool to r.t., the organic layer was washed with 
sat. aqueous NaHCO3 (2 mL), and the solvent was removed under reduced pressure. Flash column 
chromatography (Pentane:EtOAc 4:1) afforded the desired product 13a (see compound 13a’s 
characterization for all the chemical data). 
Table S3: Screening of solvents 
 









9 DMF (110°C) 66%
a) Substrate 12 (0.100 mmol), IndoleBX 9a (0.110 mmol), [Rh(Cp*Cl2)]2 
(5 mol%), Zn(OTf)2 (10 mol%) and solvent (0.1 M) at 25 °C. Isolated yield 
after flash chromatography is given. 
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Table S4: Screening of additives 
 
Entry Additive Yield%a 












a) Substrate 12 (0.100 mmol), IndoleBX 9a (0.110 mmol), [Rh(Cp*Cl2)]2 (5 
mol%), additive (10 mol%) and DCE (0.1 M) at 25 °C. Isolated yield after 
flash chromatography is given. b) incomplete conversion, remaining starting 
material completely recovered. c) decomposition observed. d) T of the 





Table S5: Screening of the catalyst:additive ratio at different T°C. 
 
Entry Catalyst (mol%) Additive (mol%) T°C Yield%a
1 [Rh(Cp*Cl2)2] 
(1.25)/AgSbF6 (2.5) 
NaOPiv (2.5) r.t. tracesb 
2 [Rh(Cp*Cl2)2] 
(1.25)/AgSbF6 (10) 
NaOPiv (10) r.t. tracesb 
3 [Rh(Cp*Cl2)2] 
(1.25)/AgSbF6 (10) 
NaOPiv (10) 40°C tracesb 
4 [Rh(Cp*Cl2)2] 
(1.25)/AgSbF6 (10) 
NaOPiv (10) 50°C 37%b 
5 [Rh(Cp*Cl2)2] 
(2.5)/AgSbF6 (5) 
NaOPiv (5)  r.t. tracesc 
6 [Rh(Cp*Cl2)2] 
(2.5)/AgSbF6 (10) 
NaOPiv (10) r.t. 78% 
7 [Rh(Cp*Cl2)2] 
(2.5)/AgSbF6 (10) 
NaOPiv (10) 50°C 82% 
8 [Rh(Cp*Cl2)2] 
(2.5)/AgSbF6 (10) 
NaOPiv (10) 80°C 85% 
9 [Rh(Cp*Cl2)2] (5)/AgSbF6 
(10) NaOPiv (10) r.t. 90% 
a)Substrate 12 (0.100 mmol), IndoleBX 9a (0.110 mmol), [Rh(Cp*Cl2)]2 (X mol%), NaOPiv (X mol%) and 
DCE (0.1 M) at 25 °C. Isolated yield after flash chromatography is given. b) the reaction time was 48 hours, 
hypervalent iodine decomposition was observed. 
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3.4 Control experiments for the Indolization of Arenes via C-H activation.      
In order to assess the superiority of our reagents in catalysis compared to other indole-transfer 
reagents already known in cross-coupling reactions, we tested the latter under different sets of 
conditions. Substrates 8a, 16 and 17 are commercially available, while compound 18 needed to be 
prepared and immediately used in the catalytic process. 
 
Substrates 8a, 16 and 17 were tested under our optimized conditions (table S6, entries 1-3) at 
different temperatures (r.t.-50-60-110 °C): no conversion was observed. The hypervalent 
indolinium salt 18 was also tested in presence of NaSbF6 (table S6, entry 4) as an alternative salt to 
promote the exchange of BF4- counteranion with SbF6-, but no conversion was observed. Substrates 
16 and 17 were then tested under established conditions for Pd-catalyzed cross couplings of C3-
halogenated indoles. 3- Bromo-N-methylindole 16 was tested under Hartwig Pd-catalyzed 
amination conditions20 (table S6, entry 5), carbonylative Sonogashira conditions21 (table S6, entry 
6) and Heck conditions22 (table S6, entry 7): the desired product was never observed. Furthermore, 
when 3-Iodo-N-methylindole 17 was tested under Suzuki and Sonogashira cross coupling 
conditions23 (table S6, entries 8-9) no product was detected.  
In Table S7 oxidative methods were examined (table S7, entries 1,4),24 Shi conditions (table S7, 
entries 2,5),25 and Fagnou conditions (table S7, entries 3,6);26 the desired compound was never 
observed.  
  
                                                 
[20] M. W. Hooper, M. Utsunomiya, J. F. Hartwig, J. Org. Chem. 2003, 68, 2861–2873. 
[21] K. T. Neumann, S. R. Laursen, A. T. Lindhardt, B. Bang-Andersen, T. Skrydstrup, Org. Lett. 2014, 16, 2216–
2219. 
[22] D. S. G. Spinella, A. Izzo, Synlett 2006, 1319–1322. 
[23] B. Witulski, J. R. Azcon, C. Alayrac, A. Arnautu, V. Collot, S. Rault, Synlett 2005, 771–780. 
[24] J. Wencel-Delord, C. Nimphius, H. Wang, F. Glorius, Angew. Chem. Int. Ed. 2012, 51, 13001–13005. 
[25] B.-J. Li, S.-L. Tian, Z. Fang, Z.-J. Shi, Angew. Chem. Int. Ed. 2008, 47, 1115–1118. 
[26] D. R. Stuart, E. Villemure, K. Fagnou, J. Am. Chem. Soc. 2007, 129, 12072–12073. 
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Table S6: Control experiments (I) 
 
Entry X Catalyst (mol%) Additive (mol%) Solvent (M) Yield%a
1 H (8a) [Rh(Cp*Cl2)2] (2.5)/AgSbF6 (10)





























































TEA (3 equiv.) 
 











TEA (3 equiv.) 
 










CuI (10)/ TEA (3 
equiv.) 
 










Na2CO3 (1 equiv.) 
 
DMF (0.1 M) - 
a)Substrate (0.100 mmol), Indole source (0.110 mmol), Catalyst (X mol%), Additive (X mol%) and Solvent (0.1 M) 




Table S7: Control experiments (II) 
 
Entry Substrate Equiv. Equiv. 8a Catalyst (mol%) Additive (mol%) 












(0.33 M)/140 °C - 
2 1 6.0 Pd(OAc)2(10) 
 
Cu(OTf)2 (20) 
O2 1 atm. 
EtCOOH  
(0.2 M)/120°C - 





neat in arene 
(0.15 M) - 
4 
 








(0.33 M)/140 °C - 
5 1 6.0 Pd(OAc)2(10) Cu(OTf)2 (20) O2 1 atm. 
EtCOOH  
(0.2 M)/120 °C - 





neat in arene 
(0.15 M)/110 °C - 
a)Reaction performed on 0.1 mmol of the limiting reagent; substrate (X mmol), Indole 8a (X mmol), Catalyst (X 





Finally, in Table S8 are reported control experiments employing conditions suitable for hypervalent 
iodine reagents such as Kita conditions (table S8, entry 1),27 Sanford conditions (table S8, entry 
2),28 and Daugulis conditions (table S8, entry 3);29 the desired compounds was not observed also 
in this case; All conditions screened in Tables S6, S7 and S8 failed to afford the desired product, 
thus demonstrating the unique reactivity of our reagents. 
 
Table S8: Control experiments (III) 
 













HFIP (0.1 M) - 




(0.1 M)/110 °C - 
3 
 
1 5 Pd(OAc)2 (5) - MeCOOH  (1.5 M)/90 °C - 
a)Reaction performed on 0.1 mmol of the limiting reagent; substrate (X mmol), Indole source 19a (X mmol), Catalyst 
(X mol%), Additive (X mol%) and Solvent (X M) at T °C.   
                                                 
[27] Y. Kita, K. Morimoto, M. Ito, C. Ogawa, A. Goto, T. Dohi, J. Am. Chem. Soc. 2009, 131, 1668–1669. 
[28] D. Kalyani, N. R. Deprez, L. V. Desai, M. S. Sanford, J. Am. Chem. Soc. 2005, 127, 7330–7331. 
[29] O. Daugulis, V. G. Zaitsev, Angew. Chem. Int. Ed. 2005, 44, 4046–4048. 
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3.5 Scope of the Rh-Catalyzed Indolization via C-H activation.  
General Procedures GP3-GP4 for Rh-Catalyzed Hetero-arylation via C-H activation   
 
GP3: In a vial, the corresponding aryl-pyridine (0.300 mmol, 1 .00 equiv.), the relative heterocyclic 
hypervalent iodine reagent 9a-9r (0.330 mmol, 1.10 equiv.), [Rh(Cp*Cl2)]2 (4.60 mg, 7.50 µmol, 
2.5 mol%), AgSbF6 (10.3 mg, 30.0 µmol, 10 mol%) and NaOPiv (3.70 mg, 30.0 µmol, 10 mol%) 
were dissolved in dry 1,2-DCE (3 ml, 0.1 M) under nitrogen. the reaction mixture was degassed 
(freeze-thaw-pump) and stirred at the reported T in °C overnight. The reaction mixture was then 
allowed to cool to r.t., the organic layer was washed with sat. aquoeus NaHCO3 (2ml), and the 
solvent was removed under reduced pressure. Flash column chromatography (Pentane:EtOAc) 
afforded the desired products 13a-13r. 
 
 
GP4: In a screw capped vial, the corresponding heterocycle (0.300 mmol, 1.00 equiv.), the relative 
heterocyclic hypervalent iodine reagent 9a (0.330 mmol, 1.10 equiv.), [Rh(Cp*Cl2)]2 (4.60 mg, 
7.50 µmol, 2.5 mol%), AgSbF6 (10.3 mg, 30.0 µmol, 10 mol%) and NaOPiv (3.70 mg, 30.0 µmol, 
10 mol%) were dissolved in dry 1,2-DCE (3 ml, 0.1M) under nitrogen. the reaction mixture was 
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degassed (freeze-thaw-pump) and stirred at the reported T in °C overnight. The reaction mixture 
was then allowed to cool to r.t., the organic layer was washed with sat. aqueous NaHCO3 (2 mL), 
and the solvent was removed under reduced pressure. Flash column chromatography 
(Pentane:EtOAc) afforded the desired products 19-25. 
 







Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol, 1.00 equiv.) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9a (124 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 2-(2-(1-methyl-1H-
pyrrol-2-yl)phenyl)pyridine 9a (60.0 mg, 0.256 mmol, 85% yield) was obtained 
as a pale yellow oil. Rf: 0.48 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) 
δ 8.65 (m, 1H, ArH), 7.73 (dd, J = 7.4, 1.7 Hz, 1H, ArH), 7.59 (m, 1H, ArH), 7.52 – 7.38 (m, 3H, 
ArH), 7.35 – 7.22 (m, 2H, ArH), 7.19 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H, ArH), 7.11 – 6.94 (m, 3H, 
ArH), 6.71 (s, 1H, NCHC), 3.70 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 159.9, 149.3, 
139.8, 136.8, 135.1, 133.3, 131.0, 130.5, 128.4, 128.2, 127.0, 126.7, 124.9, 121.6, 121.2, 119.9, 
119.5, 115.4, 109.1, 32.7. IR ν 3057 (w), 2934 (w), 1725 (w), 1586 (s), 1545 (m), 1461 (s), 1425 
(s), 1377 (s), 1330 (m), 1219 (m), 1162 (w), 1091 (w), 1024 (w), 942 (w), 910 (w). HRMS (ESI) 




Starting from commercially available 2-phenylpyridine 8 (43.0 µl, 0.300 mmol, 
1.00 equiv.) and with 1-(3-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9b 
(120 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 2-(2-(1-methyl-1H-pyrrol-2-
yl)phenyl)pyridine 13b (60.3 mg, 0.223 mmol, 74% yield) was obtained as a 
slightly brown foam. Rf: 0.30 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.63 (m, 1H, ArH), 8.40 (s, 1H, NH), 7.72 (dd, J = 7.3, 1.8 Hz, 1H, ArH), 7.60 (dd, J = 
7.3, 1.8 Hz, 1H, ArH), 7.51 – 7.39 (m, 3H, ArH), 7.33 – 7.22 (m, 2H, ArH), 7.14 (ddd, J = 8.2, 6.9, 
1.2 Hz, 1H, ArH), 7.02 (m, 3H, ArH), 6.76 (d, J = 2.5 Hz, 1H, NHCHC). 13C NMR (101 MHz, 
CDCl3) δ 159.8, 149.0, 139.8, 135.9, 135.3, 133.3, 131.0, 130.5, 128.5, 126.9, 126.6, 125.0, 123.7, 
122.0, 121.3, 119.9, 119.7, 116.7, 111.0. IR ν 3409 (w), 3170 (w), 3058 (w), 2921 (w), 1668 (w), 
1600 (m), 1589 (s), 1544 (w), 1489 (w), 1464 (s), 1332 (w), 1245 (m), 1153 (w), 1098 (w), 910 





Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 
0.300 mmol) and with 1-(3-1-(3-phenylpropyl)-1H-indole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9e (159 mg, 0.330 mmol, 1.10 equiv.) at 80 
°C, 1-(3-phenylpropyl)-3-(2-(pyridin-2-yl)phenyl)-1H-indole 13c 
(86.0 mg, 0.221 mmol, 74% yield) was obtained as an orange oil. Rf: 
0.48 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.67 (m, 1H, ArH), 7.76 (dd, J = 7.4, 
1.7 Hz, 1H, ArH), 7.67 (dd, J = 7.4, 1.5 Hz, 1H, ArH), 7.58 (d, J = 7.9 Hz, 1H, ArH), 7.51 (td, J = 
7.4, 1.7 Hz, 1H, ArH), 7.47 (td, J = 7.4, 1.5 Hz, 1H, ArH), 7.34 – 7.19 (m, 6H, ArH), 7.09 (m, 3H, 
ArH), 7.06 – 7.01 (m, 2H, ArH), 6.71 (s, 1H, CH2NCHC), 4.04 (t, J = 6.8 Hz, 2H, 
PhCH2CH2CH2N), 2.48 (dd, J = 8.6, 6.7 Hz, 2H, PhCH2CH2CH2N), 2.08 (dq, J = 9.0, 6.9 Hz, 2H, 
PhCH2CH2CH2N). 13C NMR (101 MHz, CDCl3) δ 160.0, 149.1, 140.8, 139.8, 136.0, 135.2, 133.3, 
130.9, 130.5, 128.5, 128.3, 127.4, 127.3, 126.7, 126.1, 125.1, 121.6, 121.3, 119.9, 119.6, 115.2, 
109.3, 45.4, 32.7, 31.3 (one Carbon signal not resolved). IR ν 3059 (w), 3027 (w), 2932 (w), 1602 
(w), 1585 (m), 1547 (w), 1496 (w), 1462 (s), 1424 (w), 1392 (w), 1372 (w), 1334 (w), 1167 (w), 
1024 (w), 911 (w). HRMS (ESI) calcd for C28H25N2+ [M+H]+ 389.2012; found 389.2016. 
 
5-Methoxy-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13d) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol) and with 1-(3-5-methoxy-1-methyl-1H-indole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9g (134 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 5-
methoxy-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole 13d (84.0 mg, 
0.267 mmol, 89% yield) was obtained as a yellow oil. Rf: 0.40 
(Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.67 (dd, J = 4.9, 0.9 Hz, 1H, ArH), 7.76 (dd, 
J = 7.2, 1.9 Hz, 1H, ArH), 7.56 (dd, J = 7.2, 1.9 Hz, 1H, ArH), 7.57 – 7.42 (m, 2H, ArH), 7.26 (td, 
J = 7.7, 1.9 Hz, 1H, ArH), 7.14 (d, J = 8.9 Hz, 1H, ArH), 7.10 – 7.02 (m, 2H, ArH), 6.84 (s, 1H, 
NCHC), 6.79 (dd, J = 8.9, 2.4 Hz, 1H, ArH), 6.67 (d, J = 2.4 Hz, 1H, CCHCOMe), 3.71 (s, 3H, 
NCH3), 3.64 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3) δ 159.9, 153.9, 149.3, 139.4, 135.2, 
133.4, 132.0, 131.0, 130.5, 128.5, 128.3, 126.9, 126.8, 124.9, 121.3, 115.3, 112.2, 109.8, 100.8, 
55.6, 32.9. IR ν 3051 (w), 2946 (w), 1585 (m), 1489 (s), 1463 (m), 1424 (m), 1295 (w), 1266 (s), 
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1228 (m), 1210 (s), 1181 (w), 1136 (m), 1088 (w), 1031 (m), 866 (m). HRMS (ESI) calcd for 
C21H19N2O+ [M+H]+ 315.1492; found 315.1493. 
 
5-Fluoro-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13e) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol) and with 1-(3-5-fluoro-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9h (130 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 5-fluoro-1-methyl-
3-(2-(pyridin-2-yl)phenyl)-1H-indole 13e (66.0 mg, 0.218 mmol, 73% yield) 
was obtained as a yellow oil. Rf: 0.40 (Pentane:EtOAc 4:1). 1H NMR (400 
MHz, CDCl3) δ 8.65 (d, J = 4.9 Hz, 1H, ArH), 7.71 (d, J = 7.2 Hz, 1H, ArH), 7.55 (d, J = 7.2 Hz, 
1H, ArH), 7.51 – 7.38 (m, 2H), 7.33 (t, J = 7.7 Hz, 1H, ArH), 7.17 (dd, J = 9.0, 4.3 Hz, 1H, ArH), 
7.08 (t, J = 6.3 Hz, 1H, ArH), 7.08 – 6.97 (m, 2H, ArH), 6.91 (t, J = 9.0 Hz, 1H, ArH), 6.77 (s, 1H, 
NCHC), 3.70 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 159.8, 158.0 (d, J = 234.6 Hz), 149.3, 
139.7, 135.2, 133.4, 132.9, 130.8, 130.6, 129.7, 128.5, 127.3 (d, J = 9.9 Hz), 126.9, 124.8, 121.3, 
115.5 (d, J = 4.9 Hz), 110.0 (d, J = 26.5 Hz), 109.7 (d, J = 9.7 Hz), 104.7 (d, J = 24.2 Hz), 33.0. 
19F NMR (376 MHz, CDCl3) δ -125.1. IR ν 3063 (w), 2930 (w), 1624 (m), 1585 (m), 1488 (s), 
1464 (m), 1425 (m), 1292 (w), 1192 (s), 1123 (m), 1060 (w), 873 (s). HRMS (ESI) calcd for 
C20H16FN2+ [M+H]+ 303.1292; found 303.1295 
 
5-Chloro-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13f) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol) and with 1-(3-5-chloro-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9i (136 mg, 0.330 mmol, 1.10 equiv.) at 50°C, 5-fluoro-1-methyl-3-
(2-(pyridin-2-yl)phenyl)-1H-indole 13f (77.0 mg, 0.242 mmol, 81% yield) was 
obtained as a yellow oil. Rf: 0.36 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.65 (m, 1H, ArH), 7.72 (dd, J = 7.3, 1.8 Hz, 1H, ArH), 7.55 (m, 1H, ArH), 7.46 (pd, J 
= 7.3, 1.8 Hz, 2H, ArH), 7.38 – 7.31 (m, 2H, ArH), 7.17 (d, J = 8.6 Hz, 1H, ArH), 7.14 – 7.07 (m, 
2H, ArH), 7.04 (m, 1H, ArH), 6.75 (s, 1H, NCHC), 3.69 (s, 3H, NCH3). 13C NMR (101 MHz, 
CDCl3) δ 159.6, 149.0, 139.5, 135.6, 135.2, 132.7, 131.0, 130.6, 129.4, 128.7, 128.0, 127.1, 125.5, 
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124.9, 121.9, 121.4, 119.3, 115.2, 110.2, 33.0. IR ν 3055 (w), 3014 (w), 2924 (w), 1586 (w), 1543 
(w), 1477 (s), 1424 (m), 1374 (w), 1288 (w), 1218 (w), 1152 (w), 1096 (w), 1058 (w), 953 (w). 
HRMS (ESI) calcd for C20H16ClN2+ [M+H]+ 319.0997; found 319.1006. 
 
5-Iodo-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13g) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol) and with 1-(3-5-iodo-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9j (166 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 5-Iodo-1-methyl-3-
(2-(pyridin-2-yl)phenyl)-1H-indole 13g (91.0 mg, 0.222 mmol, 74% yield) was 
obtained as a yellow oil. Rf: 0.45 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.66 (dd, J = 5.0, 0.9 Hz, 1H, ArH), 7.71 (m, 1H, ArH), 7.65 (d, J = 1.6 Hz, 1H, ArH), 
7.53 (m, 1H, ArH), 7.50 – 7.42 (m, 2H, ArH), 7.39 (dd, J = 8.5, 1.6 Hz, 1H, ArH), 7.32 (td, J = 
7.7, 1.9 Hz, 1H, ArH), 7.08 (ddd, J = 7.7, 5.0, 1.1 Hz, 1H, ArH), 7.07 – 6.97 (m, 2H, ArH), 6.70 
(s, 1H, NCHC), 3.67 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 159.7, 149.3, 139.8, 135.7, 
135.2, 132.5, 130.9, 130.5, 129.8, 129.2, 128.7, 128.7, 128.5, 127.0, 124.7, 121.4, 114.9, 111.1, 
83.2, 32.9. IR ν 3058 (w), 2920 (w), 1606 (w), 1585 (m), 1474 (s), 1422 (m), 1371 (w), 1287 (w), 
1266 (w), 1217 (w), 1148 (w), 1092 (w), 1024 (w), 943 (w), 874 (w). HRMS (ESI) calcd for 




Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol) and with 1-(3-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9k (166 mg, 0.330 mmol, 
1.10 equiv.) at 50 °C, 1-Methyl-3-(2-(pyridin-2-yl)phenyl)-5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 13h (73.0 mg, 0.178 mmol, 
59% yield) was obtained as a yellow oil. Rf: 0.30 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.64 (d, J = 5.0 Hz, 1H, ArH), 8.00 (s, 1H, ArH), 7.71 (d, J = 7.5 Hz, 1H, ArH), 7.64 (dd, 
J = 8.3, 1.1 Hz, 1H, ArH), 7.61 (m, 1H, ArH), 7.46 (td, J = 7.4, 1.7 Hz, 1H, ArH), 7.41 (td, J = 7.4, 
1.6 Hz, 1H, ArH), 7.29 – 7.26 (m, 2H, ArH), 7.00 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H, ArH), 6.95 (dt, J 
= 7.9, 1.0 Hz, 1H, ArH), 6.62 (s, 1H, ArH), 3.68 (s, 3H, NCH3), 1.34 (s, 12H, BPin). 13C NMR 
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(101 MHz, CDCl3) δ 159.9, 149.1, 140.0, 138.6, 135.0, 133.1, 131.2, 130.3, 128.4, 128.2, 127.7, 
127.7, 126.9, 126.7, 124.9, 121.1, 116.0, 108.5, 83.3, 32.6, 24.8 (one aromatic Carbon signal not 
resolved). IR ν 3063 (w), 2978 (w), 2940 (w), 2245 (w), 2214 (w), 1608 (m), 1605 (m), 1568 (w), 
1463 (m), 1438 (m), 1383 (s), 1349 (s), 1311 (s), 1273 (m), 1142 (s), 1097 (m), 967 (m), 910 (s), 
866 (m). HRMS (ESI) calcd for C26H28BN2O2+ [M+H]+ 411.2238; found 411.2248. 
 
2-(2-(1-Methyl-1H-pyrrol-3-yl)phenyl)pyridine (13i) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 mmol, 
1.00 equiv.) and with 1-(3-1-methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9o (108 mg, 0.330 mmol, 1.10 equiv.) at 80°C, 2-(2-(1-Methyl-1H-pyrrol-3-
yl)phenyl)pyridine 13i (60.0 mg, 0.256 mmol, 85% yield) was obtained as a 
yellow oil. Rf: 0.38 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.67 
(d, J = 5.0 Hz, 1H, ArH), 7.57 – 7.46 (m, 3H, ArH), 7.37 (t, J = 7.5 Hz, 1H, ArH), 7.31 (d, J = 7.5 
Hz, 1H, ArH), 7.22 (d, J = 7.9 Hz, 1H, ArH), 7.18 (dd, J = 7.4, 5.1 Hz, 1H, ArH), 6.43 (t, J = 2.5 
Hz, 1H, ArH), 6.30 (d, J = 1.6 Hz, 1H, ArH), 5.80 (d, J = 1.6 Hz, 1H, ArH), 3.54 (s, 3H, NCH3). 
13C NMR (101 MHz, CDCl3) δ 160.6, 149.1, 138.7, 135.2, 134.8, 130.2, 129.3, 128.3, 125.8, 
125.2, 123.8, 121.5, 121.3, 120.6, 109.2, 36.1. IR ν 3056 (w), 3007 (w), 2943 (w), 1586 (s), 1551 
(m), 1508 (m), 1463 (s), 1424 (s), 1361 (m), 1260 (w), 1202 (s), 1150 (w), 1087 (w), 1024 (w), 
990 (w), 926 (w). HRMS (ESI) calcd for C16H15N2+ [M+H]+ 235.1230; found 235.1230. 
 
2-(2-(1H-Pyrrol-3-yl)phenyl)pyridine (13j) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 mmol, 
1.00 equiv.) and with 1-(3-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9n (103 
mg, 0.330 mmol, 1.10 equiv.) in a mixture of 1,2-DCE:MeOH (2:1, 0.1M) at 50 
°C, 2-(2-(1H-pyrrol-3-yl)phenyl)pyridine 13j (52.0 mg, 0.236 mmol, 79% yield) 
was obtained as a light brown foam. Rf: 0.42 (Pentane:EtOAc 4:1) 1H NMR (400 
MHz, CDCl3) δ 8.67 (m, 1H, ArH), 8.29 (m, 1H, NH), 7.57 – 7.47 (m, 3H, ArH), 7.40 (dd, J = 8.2, 
6.8 Hz, 1H, ArH), 7.32 (t, J = 7.3 Hz, 1H, ArH), 7.23 – 7.15 (m, 2H, ArH), 6.62 (d, J = 2.6 Hz, 
1H, ArH), 6.43 (d, J = 2.6 Hz, 1H, ArH), 5.95 (dd, J = 2.9, 1.6 Hz, 1H, ArH). 13C NMR (101 MHz, 
CDCl3) δ 160.6, 149.2, 139.0, 135.2, 134.7, 130.2, 129.6, 128.4, 126.1, 125.2, 123.8, 121.4, 117.6, 
116.8, 109.3. IR ν 3191 (m), 3054 (m), 2928 (w), 1601 (s), 1589 (s), 1562 (m), 1505 (m), 1464 (s), 
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1426 (s), 1267 (w), 1152 (w), 1078 (w), 1028 (m), 996 (w), 917 (w). HRMS (ESI) calcd for 
C15H13N2+ [M+H]+ 221.1073; found 221.1077. 
 
2-(2-(1-Benzyl-1H-pyrrol-3-yl)phenyl)pyridine (13k) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 mmol, 
1.00 equiv.) and with 1-(3-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9q (133 mg, 0.330 mmol, 1.10 equiv.) at 80 °C, 2-(2-(1-Benzyl-1H-pyrrol-3-
yl)phenyl)pyridine 13k (54.0 mg, 0.174 mmol, 58% yield) was obtained as an pale 
yellow oil. Rf: 0.30 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.62 (m, 
1H, ArH), 7.51 – 7.45 (m, 3H, ArH), 7.38 (td, J = 7.5, 1.6 Hz, 1H, ArH), 7.34 – 
7.26 (m, 4H, ArH), 7.20 (d, J = 7.9 Hz, 1H, ArH) 7.13 (ddd, J = 7.4, 4.9, 1.2 Hz, 
1H, ArH), 7.03 – 6.97 (m, 2H, ArH), 6.54 (t, J = 2.5 Hz, 1H, ArH), 6.25 (t, J = 1.8 Hz, 1H, ArH), 
5.99 (dd, J = 2.5, 1.8 Hz, 1H, ArH), 4.92 (s, 2H, NCH2Ph). 13C NMR (101 MHz, CDCl3) δ 160.5, 
149.1, 138.8, 137.9, 135.2, 134.8, 130.1, 129.4, 128.6, 128.3, 127.6, 126.9, 126.0, 125.2, 123.9, 
121.3, 121.0, 120.4, 109.4, 53.3. IR ν 3062 (m), 2925 (m), 2854 (w), 1708 (m), 1586 (s), 1562 (m), 
1498 (s), 1463 (s), 1425 (s), 1355 (m), 1190 (m), 1082 (m), 1025 (m). HRMS (ESI) calcd for 
C22H19N2+ [M+H]+ 311.1543; found 311.1545. 
 
2-(2-(1-methyl-1H-pyrrol-2-yl)phenyl)pyridine (13l) 
Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 mmol, 
1.00 equiv.) and with 1-(2-1-methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9p (108 mg, 0.330 mmol, 1.10 equiv.) at 80 °C, 2-(2-(1-methyl-1H-pyrrol-2-
yl)phenyl)pyridine 13l (60.0 mg, 0.256 mmol, 85% yield) was obtained as a pale 
yellow oil. Rf: 0.42 (Pentane:EtOAc 4:1) 1H NMR (400 MHz, CDCl3) δ 8.67 (m, 
1H, ArH), 7.86 (d, J = 7.5 Hz, 1H, ArH), 7.55 – 7.40 (m, 4H, ArH), 7.14 (ddd, J = 
7.5, 4.9, 1.1 Hz, 1H, ArH), 6.80 (m, 1H, ArH), 6.51 (t, J = 2.3 Hz, 1H, ArH), 6.18 – 6.15 (m, 2H, 
ArH), 2.90 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 158.6, 149.5, 140.0, 135.7, 133.2, 131.8, 
131.5, 130.1, 128.5, 128.4, 123.7, 122.2, 121.5, 109.2, 107.7, 33.8. IR ν 3098 (w), 3059 (w), 2926 
(m), 2854 (w), 1707 (w), 1585 (s), 1473 (s), 1429 (s), 1310 (s), 1239 (w), 1090 (m), 1056 (m), 1024 





Starting from commercially available 2-phenylpyridine 12 (43.0 µl, 0.300 
mmol, 1.00 equiv.) and with 1-(2-1-benzyl-1H-pyrrole)-1H-1λ3 -
benzo[b]iodo-3(2H)-one 9r (133 mg, 0.330 mmol, 1.10 equiv.) at 80 °C, 2-
(2-(1-benzyl-1H-pyrrol-2-yl)phenyl)pyridine 13m (63.0 mg, 0.203 mmol, 
68% yield) as an pale yellow oil. Rf: 0.32 (Pentane:EtOAc 4:1). 1H NMR 
(400 MHz, CDCl3) δ 8.68 (d, J = 4.9 Hz, 1H, ArH), 7.85 (m, 1H, ArH), 7.53 
– 7.42 (m, 2H, ArH), 7.42 – 7.33 (m, 2H, ArH), 7.17 – 7.13 (m, 4H, ArH), 6.83 (d, J = 7.9 Hz, 1H, 
ArH), 6.72 (dd, J = 6.6, 2.9 Hz, 2H, ArH), 6.52 (m, 1H, ArH), 6.24 – 6.13 (m, 2H, ArH), 4.45 (s, 
2H, NCH2Ph). 13C NMR (101 MHz, CDCl3) δ 158.7, 149.5, 140.2, 138.1, 135.8, 133.2, 132.1, 
131.7, 130.3, 128.6, 128.6, 128.4, 127.3, 127.2, 124.2, 121.7, 110.1, 108.3, 50.6. (2 Cs overlapping 
at 121.7, shown by HSQC) IR ν 3062 (m), 3029 (w), 2925 (w), 1585 (s), 1471 (s), 1427 (s), 1311 
(m), 1298 (m), 1236 (m), 1153 (w), 1076 (m), 1024 (m), 989 (w). HRMS (ESI) calcd for 
C22H19N2+ [M+H]+ 311.1543; found 311.1542. 
 
3-(5-Methoxy-2-(pyridin-2-yl)phenyl)-1-methyl-1H-indole (13n) 
Starting from commercially available 2-(4-methoxyphenyl)pyridine (55.6 mg, 
0.300 mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9a (124 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 3-(5-methoxy-2-(pyridin-
2-yl)phenyl)-1-methyl-1H-indole 13n (83.0 mg, 0.264 mmol, 88% yield) was 
obtained as a yellow oil. Rf: 0.38 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.64 (d, J = 5.0 Hz, 1H, ArH), 7.70 (d, J = 8.5 Hz, 1H, ArH), 7.45 (d, 
J = 8.0 Hz, 1H, ArH), 7.31 – 7.23 (m, 2H, ArH), 7.20 (t, J = 7.6 Hz, 1H, ArH), 7.13 (d, J = 2.7 Hz, 
1H, ArH), 7.06 – 6.95 (m, 4H, ArH), 6.73 (s, 1H, CH3NCHC), 3.89 (s, 3H, NCH3), 3.71 (s, 3H, 
OCH3). 13C NMR (101 MHz, CDCl3) δ 159.6, 159.4, 148.9, 136.7, 135.2, 134.6, 132.3, 131.9, 
128.2, 126.8, 125.0, 121.6, 120.8, 119.9, 119.5, 115.9, 115.3, 112.6, 109.1, 55.3, 32.8. IR ν 3049 
(w), 2933 (w), 2834 (w), 1602 (s), 1568 (m), 1463 (s), 1426 (m), 1278 (s), 1232 (s), 1210 (m), 1062 






Starting from commercially available 2-(4-chlorophenyl)pyridine (57.0 mg, 
0.300 mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9a (124 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 3-(5-chloro-2-(pyridin-2-
yl)phenyl)-1-methyl-1H-indole 13o (81.2 mg, 0.255 mmol, 85% yield) was 
obtained as a yellow oil. Rf: 0.40 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.65 (m, 1H, ArH), 7.68 (d, J = 8.3 Hz, 1H, ArH), 7.59 (d, J = 2.2 Hz, 
1H, ArH), 7.40 (dd, J = 8.3, 2.2 Hz, 1H, ArH), 7.37 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.30 (dd, J = 
7.7, 1.7 Hz, 1H, ArH), 7.27 (m, 1H, ArH), 7.19 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H, ArH), 7.08 (ddd, J 
= 7.5, 4.9, 1.1 Hz, 1H, ArH), 7.04 – 6.99 (m, 2H, ArH), 6.75 (s, 1H, NCHC), 3.71 (s, 3H, NCH3). 
13C NMR (101 MHz, CDCl3) δ 158.7, 149.2, 137.9, 136.8, 135.4, 135.1, 134.3, 132.0, 130.7, 
128.4, 126.7, 126.6, 124.9, 121.8, 121.5, 119.8, 119.7, 114.3, 109.2, 32.8. IR ν 3055 (w), 2926 (w), 
1595 (s), 1566 (m), 1476 (m), 1461 (s), 1427 (w), 1329 (m), 1219 (w), 1163 (w), 1100 (m), 1026 
(w), 913 (w), 830 (w). HRMS (ESI) calcd for C20H16ClN2+ [M+H]+ 319.0997; found 319.0999. 
 
3-(5-Bromo-2-(pyridin-2-yl)phenyl)-1-methyl-1H-indole (13p) 
Starting from commercially available 2-(4-bromophenyl)pyridine (70.2 mg, 
0.300 mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9a (124 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 3-(5-methoxy-2-(pyridin-
2-yl)phenyl)-1-methyl-1H-indole 13p (91.0 mg, 0.251 mmol, 84% yield) was 
obtained as a yellow oil. Rf: 0.40 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.66 (m, 1H, ArH), 7.75 (d, J = 2.0 Hz, 1H, ArH), 7.63 (d, J = 8.3 Hz, 
1H, ArH), 7.56 (dd, J = 8.3, 2.0 Hz, 1H, ArH), 7.36 – 7.31 (m, 2H, ArH), 7.28 (dt, J = 8.2, 0.9 Hz, 
1H, ArH), 7.19 (ddd, J = 8.2, 6.9, 0.9 Hz, 1H, ArH), 7.11 (t, J = 6.3 Hz, 1H, ArH), 7.04 (d, J = 8.0 
Hz, 1H, ArH), 6.99 (m, 1H, ArH), 6.77 (s, 1H, NCHC), 3.72 (s, 3H, NCH3). 13C NMR (101 MHz, 
CDCl3) δ 158.7, 149.3, 138.5, 136.7, 135.4, 135.2, 133.5, 132.1, 129.6, 128.3, 126.5, 124.7, 122.4, 
121.8, 121.5, 119.7, 119.6, 114.2, 109.2, 32.7. IR ν 2956 (w), 2929 (w), 2851 (w), 1678 (w), 1592 
(m), 1510 (m), 1453 (m), 1453 (m), 1434 (s), 1399 (s), 1364 (s), 1264 (m), 1108 (m), 1031 (m), 




Methyl 3-(1-methyl-1H-indol-3-yl)-4-(pyridin-2-yl)benzoate (13q) 
 
Starting from methyl 4-(pyridin-2-yl)benzoate 44 (64.0 mg, 0.300 mmol) and 
with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9a (124 mg, 
0.330 mmol, 1.10 equiv.) at 50°C, methyl 3-(1-methyl-1H-indol-3-yl)-4-
(pyridin-2-yl)benzoate 13q (94.0 mg, 0.275 mmol, 92% yield) was obtained as 
an orange oil. Rf: 0.33 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 
8.61 (dd, J = 5.1, 1.6 Hz, 1H, ArH), 8.20 (d, J = 1.7 Hz, 1H, ArH), 7.99 (dd, J = 8.1, 1.8 Hz, 1H, 
ArH), 7.72 (d, J = 8.1 Hz, 1H, ArH), 7.26 (d, J = 8.0 Hz, 1H, ArH), 7.24 – 7.16 (m, 2H, ArH), 7.09 
(t, J = 7.6 Hz, 1H, ArH), 7.03 – 6.96 (m, 2H, ArH), 6.90 (t, J = 7.5 Hz, 1H, ArH), 6.71 (s, 1H, 
NCHC), 3.85 (s, 3H, COOMe), 3.61 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 167.0, 158.8, 
149.4, 143.8, 136.8, 135.3, 133.7, 132.3, 130.7, 129.9, 128.3, 127.6, 126.7, 124.7, 121.8, 121.7, 
119.7, 114.7, 109.1, 52.1, 32.8 (two aromatic Carbon signals overlapping at 119.7). IR ν 3052 
(w), 2950 (w), 2252 (w), 2218 (w), 1718 (s), 1587 (m), 1436 (m), 1365 (m), 1330 (m), 1286 (s), 
1251 (s), 1162 (m), 1113 (m), 994 (w), 911 (s). HRMS (ESI) calcd for 
C22H19N2O2+ [M+H]+ 343.1441; found 343.1438. 
 
3-(1-Methyl-1H-indol-3-yl)-4-(pyridin-2-yl)benzonitrile (13r) 
Starting from commercially available 4-(pyridin-2-yl)benzonitrile (54.0 mg, 
0.300 mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 9a (124 mg, 0.330 mmol, 1.10 equiv.) at 80 °C, 3-(1-methyl-1H-indol-3-
yl)-4-(pyridin-2-yl)benzonitrile 13r (72.0 mg, 0.233 mmol, 78% yield) was 
obtained as a yellow oil. Rf: 0.35 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.70 (m, 1H, ArH), 7.88 (d, J = 1.7 Hz, 1H, ArH), 7.83 (d, J = 8.0 Hz, 
1H, ArH), 7.69 (dd, J = 8.0, 1.7 Hz, 1H, ArH), 7.36 – 7.27 (m, 3H, ArH), 7.21 (ddd, J = 8.3, 7.0, 
1.1 Hz, 1H, ArH), 7.13 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H, ArH), 7.05 (d, J = 8.0 Hz, 1H, ArH), 7.02 
(ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 6.77 (s, 1H, NCHC), 3.73 (s, 3H, NCH3). 13C NMR (101 
MHz, CDCl3) δ 157.9, 149.6, 143.6, 136.7, 135.6, 134.8, 134.5, 131.5, 129.8, 128.4, 126.3, 124.7, 
122.2, 122.0, 120.1, 119.3, 118.9, 113.3, 112.1, 109.4, 32.9. IR ν 3053 (w), 2932 (w), 2230 (m), 
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1587 (m), 1558 (w), 1475 (m), 1463 (m), 1330 (w), 1266 (s), 1224 (w), 1160 (w), 1091 (w), 1026 
(w), 902 (w), 839 (m). HRMS (ESI) calcd for C21H16N3+ [M+H]+ 310.1339; found 310.1344. 
 
Methyl 3,5-bis(1-methyl-1H-indol-3-yl)-4-(pyridin-2-yl)benzoate (19) 
Starting from methyl 4-(pyridin-2-yl)benzoate 44 (64.0 mg, 0.300 
mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9a (249 mg, 0.660 mmol, 2.20 equiv.) at 50 °C, methyl 
3,5-bis(1-methyl-1H-indol-3-yl)-4-(pyridin-2-yl)benzoate 19 (75.0 
mg, 0.159 mmol, 53% yield) was obtained as a yellow oil. Rf: 0.30 
(Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.47 (m, 1H, 
ArH), 8.32 (s, 2H, ArH), 7.68 (d, J = 8.0 Hz, 2H, ArH), 7.29 – 7.15 (m, 5H, ArH), 7.08 (ddd, J = 
8.2, 6.5, 1.5 Hz, 2H, ArH), 6.99 – 6.93 (m, 2H, ArH), 6.52 (s, 2H, ArH), 3.94 (s, 3H, COOMe), 
3.58 (s, 6H, NMe). 13C NMR (101 MHz, CDCl3) δ 167.2, 159.8, 147.9, 143.2, 136.4, 135.6, 135.4, 
129.7, 128.9, 127.3, 125.7, 121.6, 121.5, 119.8, 119.5, 114.5, 109.0, 52.1, 32.6. IR ν 3056 (w), 
2950 (w), 2247 (w), 1720 (m), 1571 (m), 1477 (m), 1427 (m), 1325 (m), 1293 (s), 1247 (s), 1161 




Starting from commercially available 2-phenylpyrimidine (47.0 mg, 0.300 
mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9a (124 mg, 0.330 mmol, 1.10 equiv.) at 80 °C, 1-methyl-3-(2-(pyrimidin-2-
yl)phenyl)-1H-indole 20 (69.0 mg, 0.242 mmol, 81% yield) was obtained as a 
yellow oil. Rf: 0.40 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.58 
(d, J = 4.9 Hz, 2H, PyrimidineH), 7.84 (dd, J = 7.7, 1.5 Hz, 1H, ArH), 7.59 (dd, J = 7.7, 1.5 Hz, 
1H, ArH), 7.51 (m, 1H, ArH), 7.44 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.24 (d, J = 8.2 Hz, 1H, ArH), 
7.10 (dd, J = 9.3, 7.5 Hz, 2H, ArH), 7.03 (s, 1H, NCHCI), 7.00 (t, J = 4.9 Hz, 1H, ArH), 6.84 (t, J 
= 7.5 Hz, 1H, ArH), 3.76 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 168.5, 156.7, 138.1, 
136.7, 134.1, 131.3, 130.7, 129.4, 127.5, 126.8, 126.5, 121.3, 119.3, 119.2, 118.2, 116.2, 109.0, 
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32.8 (two aromatic Carbon signals overlapping at 156.7). IR ν 3048 (w), 2932 (w), 1599 (w), 1568 
(s), 1554 (m), 1473 (w), 1414 (s), 1377 (w), 1330 (w), 1268 (w), 1221 (w), 1162 (w), 1135 (w), 
1015 (w), 943 (w), 822 (w). HRMS (ESI) calcd for C19H16N3+ [M+H]+ 286.1339; found 286.1344. 
 
3-(2-(1H-Pyrazol-1-yl)phenyl)-1-methyl-1H-indole (21) 
Starting from commercially available 1-phenyl-1H-pyrazole (43.0 mg, 0.300 
mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9a 
(124 mg, 0.330 mmol, 1.10 equiv.) at 80 °C, 3-(2-(1H-pyrazol-1-yl)phenyl)-1-
methyl-1H-indole 21 (59.0 mg, 0.216 mmol, 72% yield) was obtained as a 
yellow oil. Rf: 0.40 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 7.69 
(dd, J = 7.8, 1.6 Hz, 1H, ArH), 7.67 (d, J = 1.7 Hz, 1H, ArH), 7.62 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 
7.52 – 7.44 (m, 2H, ArH), 7.40 (td, J = 7.8, 1.6 Hz, 1H, ArH), 7.31 (d, J = 8.2 Hz, 1H, ArH), 7.25 
– 7.20 (m, 2H, ArH), 7.07 (m, 1H, ArH), 6.60 (s, 1H, NCHC), 6.15 (m, 1H, ArH), 3.72 (s, 3H, 
NCH3). 13C NMR (101 MHz, CDCl3) δ 139.9, 138.5, 136.7, 131.1, 131.0, 130.6, 128.2, 127.6, 
127.0, 126.9, 126.6, 121.8, 119.9, 119.3, 112.0, 109.3, 106.2, 32.8. IR ν 3049 (w), 2926 (m), 2853 
(w), 1680 (w), 1615 (w), 1604 (w), 1548 (m), 1518 (s), 1473 (s), 1423 (w), 1394 (s), 1378 (s), 1329 
(s), 1264 (w), 1221 (m), 1089 (m), 1045 (s), 1019 (m), 936 (s). HRMS (ESI) calcd for 
C18H16N3+ [M+H]+ 274.1339; found 274.1343. 
 
10-(1-Methyl-1H-indol-3-yl)benzo[h]quinoline (22) 
Starting from commercially available benzo[h]quinoline (54.0 mg, 0.300 
mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
9a (124 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 10-(1-methyl-1H-indol-3-
yl)benzo[h]quinoline 22 (70.0 mg, 0.227 mmol, 76% yield) was obtained as 
a light yellow oil. Rf: 0.40 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.27 (d, J = 2.4 Hz, 1H, ArH), 8.10 (dd, J = 8.0, 1.9 Hz, 1H, ArH), 7.93 – 7.90 (m, 1H, 
ArH), 7.88 (d, J = 8.7 Hz, 1H, ArH), 7.75 – 7.65 (m, 3H, ArH), 7.37 (d, J = 8.2 Hz, 1H, ArH), 7.29 
(m, 1H, ArH), 7.24 (m, 1H, ArH), 7.16 (ddd, J = 8.2, 4.7, 3.5 Hz, 1H, ArH), 6.79 (s, 1H, NCHC), 
6.78 (t, J = 1.1 Hz, 1H, ArH), 3.93 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 147.0, 146.8, 
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137.0, 135.4, 135.3, 133.9, 132.8, 129.7, 128.5, 128.4, 127.8, 127.5, 127.4, 127.1, 126.2, 125.7, 
121.0, 120.8, 120.7, 118.5, 108.9, 32.9. IR ν 3046 (m), 2929 (m), 1677 (w), 1615 (w), 1588 (m), 
1569 (m), 1475 (s), 1418 (s), 1375 (s), 1323 (s), 1263 (w), 1230 (s), 1161 (w), 1129 (w), 1014 (w), 
910 (m). HRMS (ESI) calcd for C22H17N2+ [M+H]+ 309.1386; found 309.1398. 
 
1'-Methyl-1-(pyrimidin-2-yl)-1H,1'H-2,3'-biindole (23) 
Starting from 1-(pyrimidin-2-yl)-1H-indole 46 (59.0 mg, 0.300 mmol) and 
with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9a (124 
mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 1'-methyl-1-(pyrimidin-2-yl)-
1H,1'H-2,3'-biindole 23 (80.0 mg, 0.247 mmol, 82% yield) was obtained 
as a yellow oil. Rf: 0.38 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, 
CDCl3) δ 8.51 (d, J = 4.8 Hz, 2H, ArH), 8.01 (m, 1H, ArH), 7.56 (dd, J = 
7.9, 1.3 Hz, 1H, ArH), 7.22 – 7.14 (m, 3H, ArH), 7.13 (s, 1H, ArH), 7.06 (dd, J = 8.3, 6.9 Hz, 2H, 
ArH), 6.93 (t, J = 4.8 Hz, 1H, ArH), 6.82 (td, J = 7.4, 0.9 Hz, 1H, ArH), 6.69 (s, 1H, CH3NCHC), 
3.71 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 158.2, 158.2, 137.5, 136.8, 134.6, 129.6, 127.8, 
126.8, 122.6, 121.8, 121.7, 120.0, 119.8, 119.5, 117.5, 112.4, 109.3, 108.9, 106.5, 32.9. IR ν 3049 
(w), 2931 (w), 1592 (w), 1563 (m), 1454 (m), 1423 (s), 1372 (w), 1350 (w), 1309 (m), 1258 (w), 
1217 (w), 910 (w). HRMS (ESI) calcd for C21H17N4+ [M+H]+ 325.1448; found 325.1452. 
 
8-(1-Methyl-1H-indol-3-yl)quinolin-2(1H)-one (24) 
Starting from commercially available quinoline 1-oxide (44.0 mg, 0.300 mmol) 
and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 9a (124 
mg, 0.330 mmol, 1.10 equiv.) at 100 °C, 8-(1-methyl-1H-indol-3-yl)quinolin-
2(1H)-one 24 (31.0 mg, 0.113 mmol, 38% yield) was obtained as a yellow oil. 
Rf: 0.58 (EtOAc:MeOH 10:1). 1H NMR (400 MHz, CDCl3) δ 9.02 (s, 1H, 
NHCO), 7.83 (d, J = 9.5 Hz, 1H, ArH), 7.61 – 7.54 (m, 2H, ArH), 7.45 (dd, J 
= 8.3, 6.7 Hz, 2H, ArH), 7.34 (m, 1H, ArH), 7.30 (d, J = 7.6 Hz, 1H, ArH), 7.23 (s, 1H, NCHC), 
7.20 – 7.15 (m, 1H, IndoleH), 6.66 (d, J = 9.3 Hz, 1H, ArH), 3.91 (s, 3H, NCH3). 13C NMR (101 
MHz, CDCl3) δ 162.4, 141.0, 136.3, 132.2, 127.8, 127.7, 126.9, 126.7, 122.9, 122.4, 121.9, 121.6, 
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120.6, 120.0, 119.4, 109.8, 109.4, 33.1. IR ν 3367 (w), 3053 (w), 2923 (m), 2853 (w), 1715 (w), 
1651 (s), 1608 (m), 1541 (w), 1467 (m), 1372 (w), 1333 (w), 1234 (w), 1135 (w), 1014 (w), 840 
(m). HRMS (ESI) calcd for C18H15N2O+ [M+H]+ 275.1179; found 275.1185.  
 
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-(2-(1-methyl-1H-indol-3-yl)phenyl)-9H-purin-9-
yl)tetrahydrofuran-3,4-diyl diacetate (25) 
Starting from (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-phenyl-9H-
purin-9-yl)tetrahydrofuran-3,4-diyl diacetate 50 (136 mg, 0.300 
mmol) and with 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 9a (124 mg, 0.330 mmol, 1.10 equiv.) at 50 °C, 
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-(2-(1-methyl-1H-indol-
3-yl)phenyl)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate 25 
(72 mg, 0.123 mmol, 41% yield)) was obtained as a yellow oil. 
Rf: 0.65 (EtOAc 100%). 1H NMR (400 MHz, CDCl3) δ 8.81 (s, 1H, ArH), 8.04 (s, 1H, ArH), 7.76 
(dd, J = 7.6, 1.4 Hz, 1H, ArH), 7.70 (dd, J = 7.6, 1.3 Hz, 1H, ArH), 7.56 (td, J = 7.6, 1.5 Hz, 1H, 
ArH), 7.46 (td, J = 7.5, 1.3 Hz, 1H, ArH), 7.30 – 7.23 (m, 1H, ArH + CDCl3), 7.18 (d, J = 8.3 Hz, 
1H, ArH), 7.08 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H, ArH), 6.90 (s, 1H, ArH), 6.86 (ddd, J = 8.0, 6.9, 1.0 
Hz, 1H, ArH), 6.18 (d, J = 5.1 Hz, 1H, CH), 5.89 (t, J = 5.3 Hz, 1H, CH), 5.65 (dd, J = 5.5, 4.5 Hz, 
1H, CH), 4.47 – 4.40 (m, 2H, CH + CH2), 4.34 (dd, J = 13.1, 5.2 Hz, 1H, CH2), 3.67 (s, 3H, NMe), 
2.14 (s, 3H, COCH3), 2.08 (s, 3H, COCH3), 2.06 (s, 3H, COCH3). 13C NMR (101 MHz, CDCl3) δ 
170.3, 169.5, 169.2, 160.3, 152.3, 151.0, 142.4, 136.6, 134.7, 134.2, 132.9, 131.3, 131.0, 129.8, 
128.2, 126.9, 126.2, 121.4, 119.5, 119.2, 115.4, 109.0, 86.3, 80.2, 73.0, 70.5, 62.9, 32.7, 20.7, 20.5, 
20.4. IR ν 3056 (w), 2934 (w), 2825 (w), 2254 (w), 1749 (s), 1586 (m), 1505 (w), 1484 (w), 1435 
(w), 1377 (m), 1332 (m), 1219 (s), 1101 (m), 1048 (m), 912 (m), 817 (w). HRMS  (ESI) calcd for 










4. Ru-Catalyzed C-H Indolization of Arenes via C-H activation. 
4.1 Preparation of starting materials for Ru-Catalyzed C-H activation. 
 
GP5: Following a reported procedure,30 O-methylhydroxylamine hydrochloride (0.418 g, 5.00 
mmol, 1.00 equiv.) was added to a solution of K2CO3 (1.38 g, 10.0 mmol, 2.00 equiv) in a mixture 
of EtOAc/H2O (20 mL,1:1 0.25 M) under vigorous stirring. Then the reaction mixture was cooled 
to 0 °C and the corresponding (substituted) benzoyl chloride (5.00 mmol, 1.00 equiv) was added 
dropwise or portionwise. The reaction mixture was warmed to room temperature and stirred for 
additional 2 hours. The organic layer was separated and the aqueous layer was extracted with 
EtOAc (3x10 mL). The combined organic layers were dried over MgSO4, filtered, and the solvent 
removed under reduced pressure. The crude product was purified by flash column chromatography 
(Pentane:EtOAc 2:1) to afford the desired N-methoxy benzamides 14-62. 
                                                 
[30]  Y. Fukui, P. Liu, Q. Liu, Z.-T. He, N.-Y. Wu, P. Tian, G.-Q. Lin, J. Am. Chem. Soc. 2014, 136, 15607–15614. 
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Figure S4: Starting materials for Ru-catalyzed Indolization of Arenes via C-H activation.. 
 
N-Methoxybenzamide (14) 
The synthesis of N-methoxybenzamide 14 was scaled up to 10 mmol without 
reoptimization of the protocol. 
Starting from commercially available benzoyl chloride (1.15 mL, 10.0 mmol), N-
methoxybenzamide 14 (1.20 g, 7.94 mmol, 79% yield) was obtained as a colorless 
solid. 1H NMR (400 MHz, CDCl3) δ 10.70 (s, 1H, NHOCH3), 7.70 (dd, J = 8.3, 1.4 
Hz, 2H, ArH), 7.38 (m, 1H, ArH), 7.26 (ddd, J = 8.3, 6.6, 1.3 Hz, 2H, ArH), 3.69 (s, 3H, NHOCH3). 
13C NMR (100 MHz, CDCl3) δ 166.2, 131.7, 128.3, 127.1, 63.9, 53.3. IR ν 3197 (w), 2980 (w), 
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2935 (w), 1646 (s), 1579 (m), 1516 (m), 1484 (m), 1310 (m), 1154 (w), 1045 (m), 1026 (m), 945 
(w), 881 (s). NMR values are in accordance with the data reported in literature.30 
 
N-Methoxy-4-methylbenzamide (53) 
Starting from commercially available 4-methylbenzoyl chloride (775 mg, 5.00 mmol), 
N-methoxy-4-methylbenzamide 53 (822 mg, 4.98 mmol, 100% yield) was obtained as 
a colorless solid. 1H NMR (400 MHz, CDCl3) δ 10.73 (brs, 1H, NHOCH3), 7.67 (d, J 
= 8.2 Hz, 2H, ArH), 7.10 (d, J = 8.0 Hz, 2H, ArH),  3.74 (s, 3H, NHOCH3), 2.30 (s, 
3H, ArCH3). 13C NMR (100 MHz, CDCl3) δ (ppm) 166.2, 142.1, 128.9, 127.1, 63.8, 
21.2 (2 aromatic Carbon signals overlapping at 128.9). IR ν 3201 (w), 2975 (w), 2935 
(w), 1646 (s), 1572 (w), 1494 (m), 1439 (w), 1308 (m), 1155 (w), 1043 (s), 1020 (m), 943 (w), 883 
(s), 833 (m). NMR values are in accordance with the data reported in literature. 30 
 
N,4-dimethoxybenzamide (54) 
Starting from commercially available 4-methoxybenzoyl chloride (853 mg, 5.00 
mmol), 4-fluoro- N,4-dimethoxybenzamide 54 (890 mg, 4.91 mmol, 98% yield) was 
obtained as a white solid. 1H NMR (400 MHz, CDCl3) δ 10.67 (s, 1H, NHOMe), 7.77 
(d, J = 8.9 Hz, 2H, ArH), 6.81 (d, J = 8.4 Hz, 2H, ArH), 3.77 (s, 3H, NHOMe), 3.76 
(s, 3H, ArOMe). 13C NMR (100 MHz, CDCl3) δ 162.2, 132.6, 128.9, 114.0, 113.5, 
63.8, 55.1. IR ν 3205 (w), 2972 (w), 2938 (w), 1644 (m), 1606 (s), 1496 (m), 1255 (s), 
1181 (m), 1159 (m), 1027 (s), 884 (m), 844 (m). NMR values are in accordance with the data 
reported in literature. 30 
 
4-Fluoro-N-methoxybenzamide (55) 
Starting from commercially available 4-fluorobenzoyl chloride (793 mg, 5.00 mmol), 
4-fluoro-N-methoxybenzamide 55 (643 mg, 3.80 mmol, 76% yield) was obtained as a 
colorless solid. 1H NMR (400 MHz, CDCl3) δ 11.29 (s, 1H, NHOMe), 7.78 (m, 2H, 
ArH), 6.96 (m, 2H, ArH), 3.72 (s, 3H, NHOMe).  13C NMR (101 MHz, CDCl3) 165.2, 
164.7 (d, J = 252.5 Hz), 129.6 (d, J = 9.0 Hz), 127.6 (d, J = 3.3 Hz), 115.3 (d, J = 22.0 
S61 
 
Hz), 63.7.  IR ν 3210 (w), 2984 (w), 2941 (w), 1656 (s), 1592 (s), 1481 (s), 1439 (w), 1318 (w), 




Starting from commercially available 4-bromobenzoyl chloride (1.09 g, 5.00 mmol), 
4-bromo-N-methoxybenzamide 56 (700 mg, 3.04 mmol, 61% yield) was obtained as a 
colorless solid. 1H NMR (400 MHz, CDCl3) δ 10.59 (brs, 1H, NHOCH3), 7.56 (d, J = 
8.5 Hz, 2H, ArH), 7.41 (d, J = 8.6 Hz, 2H), 3.71 (s, 3H, NHOCH3). 13C NMR (100 
MHz, CDCl3) δ 165.4, 131.7, 130.4, 128.8, 126.7, 64.1. IR ν 3059 (w), 3006 (w), 1647 
(s), 1604 (s), 1497 (s), 1267 (s), 1237 (s), 1158 (m), 1041 (m), 885 (m), 850 (s) 1H 
NMR data is corresponding to the reported values. 30 
 
N-Methoxy-3-methylbenzamide (57) 
Starting from commercially available 3-methylbenzoyl chloride (775 mg, 5.00 
mmol), N-methoxy-3-methylbenzamide 57 (813 mg, 4.92 mmol, 98% yield) was 
obtained as a white solid. 1H NMR (400 MHz, CDCl3) δ (ppm) 11.09 (s, 1H, 
NHOCH3), 8.37 (s, 1H, ArH), 8.03 (dt, J = 7.8, 1.5 Hz, 1H), 7.98 (dt, J = 7.8, 1.5 
Hz, 1H), 7.39 (t, J = 7.8 Hz, 1H), 3.78 (s, 6H, NHOMe + ArCH3). 13C NMR (101 
MHz, CDCl3) δ 166.0, 132.4, 132.0, 131.6, 130.1, 128.5, 128.1, 63.9, 52.1. IR ν 3004 (w), 2953 
(w), 1726 (s), 1650 (m), 1516 (w), 1439 (m), 1303 (m), 1264 (s), 1156 (m), 1109 (w), 982 (w), 826 
(w). NMR values are in accordance with the data reported in literature. 30 
 
N-Methoxy-3-(trifluoromethyl)benzamide (58) 
Starting from commercially available 3-(trifluoromethyl)benzoyl chloride (1.04 
g, 5.00 mmol), N-methoxy-4-methylbenzamide 58 (822 mg, 3.75 mmol, 75% 
yield) was obtained as a colorless solid. 1H NMR (400 MHz, CDCl3) δ 9.60 (s, 
1H, NHOCH3), 8.02 (s, 1H, ArH), 7.95 (d, J = 8.1 Hz, 1H, ArH), 7.56 (t, J = 7.8 
Hz, 1H, ArH), 3.87 (s, 3H, NHOCH3). 13C NMR (100 MHz, CDCl3) δ 168.3, 
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130.5, 129.3, 128.7, 128.6, 124.2, 124.2, 123.5 (q, JF = 272.6 Hz), 64.6. IR ν 3190 (w), 2995 (w), 
1656 (m), 1522 (w), 1440 (w), 1330 (s), 1283 (m), 1169 (s), 1125 (s), 1075 (m), 909 (w). NMR 
values are in accordance with the data reported in literature.31 
 
3-Fluoro-N-methoxybenzamide (59) 
Starting from commercially available 3-fluorobenzoyl chloride (775 mg, 5.00 
mmol), 3-fluoro-N-methoxybenzamide 59 (710 mg, 4.20 mmol, 84% yield) was 
obtained as a colorless solid. Mp: 67.9°C. 1H NMR (400 MHz, CDCl3) δ 10.76 
(brs, 1H, NHOCH3), 7.57 (m, 1H, ArH), 7.50 (ddd, J = 9.4, 2.6, 1.6 Hz, 1H, ArH), 
7.30 – 7.21 (m, 1H, ArH), 7.08 (t, J = 8.8 Hz, 1H, ArH), 3.73 (s, 3H, NHOCH3). 
13C NMR (101 MHz, CDCl3) δ 165.0, 162.4 (d, J = 247.6 Hz), 133.7 (d, J = 6.9 Hz), 130.1 (d, J = 
7.8 Hz), 122.8, 118.9 (d, J = 21.2 Hz), 114.4 (d, J = 23.3 Hz), 64.0. IR 2979 (w), 2940 (w), 1652 
(s), 1587 (s), 1519 (m), 1483 (m), 1226 (s), 1046 (m), 937 (m), 816 (s). Mp and IR significative 
values are in accordance with the data reported in literature.32 
 
3-Chloro-N-methoxybenzamide (60) 
Starting from commercially available 3-chlorobenzoyl chloride (875 g, 5.00 
mmol), 3-chloro-N-methoxybenzamide 60 (830 mg, 4.47 mmol, 89% yield) was 
obtained as a white solid. 1H NMR (400 MHz, CDCl3): δ 9.90 (br s, 1H, NHOCH3), 
7.75 (s, 1H, ArH), 7.64 (d, J = 7.8 Hz, 1H, ArH), 7.45 (dd, J = 8.1, 2.1 Hz, 1H, 
ArH), 7.32 (t, J = 7.9 Hz, 1H, ArH), 3.83 (s, 3H, NHOCH3). 13C NMR (101 MHz, 
CDCl3): δ 165.1, 134.7, 133.4, 132.0, 129.9, 127.5, 125.3, 64.4. IR ν 3187 (w), 
3006 (w), 2937 (w), 1646 (s), 1572 (s), 1519 (m), 1471 (m), 1298 (m), 1162 (m), 1048 (m), 944 
(m), 904 (m). NMR values are in accordance with the data reported in literature.33 
                                                 
[31] N. Guimond, S. I. Gorelsky, K. Fagnou, J. Am. Chem. Soc. 2011, 133, 6449–6457. 
[32] V.P. Semenov, O.B. Ratner, K.A. Ogloblin, Zhurnal Organicheskoi Khimii 1979, 15, 1870–1873. Compound 59 
is purchaseable via Adlab Chemicals Building Blocks and Aurora Building Blocks. 





Starting from commercially available benzo[d][1,3]dioxole-5-carbonyl chloride 
(923 mg, 5.00 mmol), N-methoxybenzo[d][1,3]dioxole-5-carboxamide 61 (865 mg, 
4.43 mmol, 89% yield) was obtained as a white solid. 1H NMR (400 MHz, CDCl3) 
δ 10.59 (br s, 1H, NHOCH3), 7.31 (d, J = 8.2, 1.8 Hz, 1H, ArH), 7.23 (s, 1H, ArH), 
6.69 (d, J = 8.1, Hz, 1H, ArH), 5.92 (s, 2H, OCH2O), 3.75 (s, 3H, NHOCH3). 13C 
NMR (101 MHz, CDCl3) δ 165.7, 150.4, 147.6, 125.5, 122.1, 107.8, 107.5, 101.5, 
63.9. IR ν 2982 (w), 2938 (w), 1650 (m), 1605 (m), 1478 (s), 1438 (m), 1300 (m), 1252 (s), 1093 
(m), 1034 (s), 927 (s), 839 (m). HRMS (ESI) calcd for C9H10NO4+ [M+H]+ 196.0604; found 
196.0604. 
    
N-Methoxy-1-naphthamide (62) 
For this starting material the synthesis was performed on 1.00 mmol scale 
Starting from commercially available 1-naphthoyl chloride (191 mg, 1.00 mmol), 
N-methoxy-1-naphthamide 62 (183 mg, 0.909 mmol, 91% yield) was obtained as 
a white solid. 1H NMR (300 MHz, DMSO-d6) δ 8.72 (br s, 1H, NHOCH3), 8.28 
(m, 1H, ArH), 8.10–7.90 (m, 2H, ArH), 7.71–7.41 (m, 4H, ArH), 3.94 (s, 3H, 
NHOCH3). 13C NMR (75 MHz, CDCl3) δ 167.3, 133.6, 131.4, 130.3, 129.6, 128.3, 127.4, 126.6, 
125.6, 125.1, 124.5, 64.8. IR 2943 (w), 2907 (w), 2827 (w), 1631 (s), 1617 (s), 1591 (m), 1537 
(w), 1318 (w), 1262 (w), 1063 (m), 958 (m), 889 (w). NMR values are in accordance with the data 
reported in literature.34 
 
  
                                                 
[34] S. Rakshit, C. Grohmann, T. Besset, F. Glorius, J. Am. Chem. Soc. 2011, 133, 2350–2353. 
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4.2 Optimization of the Ru-Catalyzed Indolization of Arenes via C-H activation. 
GP5: In a vial, N-methoxybenzamide 14 (15.0 mg, 0.100 mmol), 1-(3-1-methyl-1H-indole)-1H-
1λ3 -benzo[b]iodo-3(2H)-one 9a (1.10 equiv.), [RuCl2(p-cymene)]2 67 (2.45 mg, 4.00 µmol, 4 
mol%) and the relative additives (16 mol%) were dissolved in the specified dry solvent (0.1 M) 
under nitrogen. the reaction mixture was degassed (freeze-thaw-pump) and stirred at the reported 
T in °C overnight. Then the reaction was stopped, the organic layer washed with a saturated 
solution of NaHCO3 (2 ml) and the solvent removed under reduced pressure. Flash column 
chromatography (Pentane:EtOAc 2:1) afforded the desired product 15a (see compound 15a’s 
characterization for all the chemical data).  
 
Table S9: Screening of solvents  
 










10 MeCN - 
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11 DMF - 
12 2,2,2-Trifluoroethanol (TFE) 55% 
13 Hexafluoroisopropanol (HFIP) 30% 
14 Nonafluoroisopropanol (NFIP):HFIP 1:9 - 
15 HFIP:DCE 9:1 - 
16 HFIP:DCE 8:2 35% 
17 HFIP:DCE 1:1 - 
18 Monofluoroethanol (MFE) 21% 
a) Substrate 14 (0.100 mmol), IndoleBX 9a (0.110 mmol), 
[Ru(pCymeneCl2)]2 67 (4 mol%), NaOAc (16 mol%) and solvent (0.1 M) 
at 60 °C. Isolated yield after flash chromatography is given. 
Table S10: Screening of the Temperature 
 
Entry T Yield%a 
1 r.t -b
2 40 low conversionb 
3 60 55%
4 80 low conversionc 
5 120 -c
a) Substrate 14 (0.100 mmol), IndoleBX 9a (0.110 mmol), 
[Ru(pCymeneCl2)]2 67 (4 mol%), NaOAc (16 mol%) and TFE (0.1 M) at T 
°C. Isolated yield after flash chromatography is given. b) clean reaction, 
starting material recovered. c) decomposition occurred. 
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Table S11: Screening of the base  
 
Entry Base Yield%a 
1 LiOPiv - 
2 Li2CO3 - 
3 LiMes -b 
4 NaOAc 55% 
5 Na2CO3 - 
6 NaOPiv 50% 
7 NaMes 34% 
8 63 -b 
9 64 68%c 
10 65 65%b 
11 66 66%b 
12 KOAc - 
13 KOPiv - 
14 KMes 26%b 
15 CsOPiv - 
16 Cs2CO3 - 
a) Substrate 14 (0.100 mmol), IndoleBX 9a (0.110 mmol), 
[Ru(pCymeneCl2)]2 67 (4 mol%), base (16 mol%) and TFE (0.1 M) at 60 
°C. Isolated yield after flash chromatography is given. b) decomposition 





Table S12: Screening of the silver(I) additive 











a) Substrate 21 (0.100 mmol), IndoleBX 5a (0.110 mmol), 
[Ru(pCymeneCl2)]2 65 (4 mol%), NaCOOAd (16 mol%), silver(I) 
additive (16 mol%) and TFE (0.1 M) at 60 °C. Isolated yield after flash 
chromatography is given. b) decomposition occurred. c) clean reaction, 








4.3 Preparation of the Ruthenium Catalyst 68. 
Following a reported procedure,35 [RuCl2(p-cymene)]2 67 (105 mg, 0.163 mmol), adamantane-1-
carboxylic acid (118 mg, 0.652 mmol, 4.00 equiv.) and K2CO3 (225 mg, 1.63 mmol, 10.0 equiv.) 
were suspended in toluene (16.0 mL, 0.01 M) under N2. The resulting suspension was stirred for 3 
hours at r.t.. The solvent was then removed in vacuo and the residue dissolved in dry CH2Cl2 (20 
mL). The resulting suspension was filtered under N2 through a short plug of celite. The solvent was 
removed in vacuo to yield (catalyst) complex 68 (90.0 mg, 0.156 mmol, 96% yield) as an orange 
solid. 1H NMR (300 MHz, CDCl3): δ 5.70 (d, J = 5.7 Hz, 2H, ArH), 5.49 (d, J = 5.7 Hz, 2H, ArH), 
2.88 (hept, J = 7.1 Hz, 1H, ArCH(CH3)2), 2.23 (s, 3H, ArCH3), 1.92 (t, J = 3.3 Hz, 6H, 
ArCH(CH3)2), 1.78 (s, 12H, AdCH2), 1.63 (s, 12H, AdCH2), 1.33 (d, J = 6.9 Hz, 6H, AdCH). 1H-
NMR values are in accordance with the data reported in literature.35 
     
  
                                                 
[35] L. Ackermann, P. Novák, R. Vicente, N. Hofmann, Angew. Chem. Int. Ed. 2009, 48, 6045–6048. 
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4.4 Scope of the Ru-Catalyzed Indolization via C-H activation.   
 
GP6: In a vial, freshly synthetized benzamide 14-62 (50.0 mg, 0.300 mmol), 1-(3-1-methyl-1H-
indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (0.330 mmol, 1.10 equiv.) and freshly synthetized 
Ruthenium complex 68 (18.2 mg, 30.0 µmol, 10 mol%), were dissolved in dry TFE (3 ml, 0.1 M) 
under nitrogen. the reaction mixture was degassed (freeze-thaw-pump) and stirred at 60 °C 
overnight. It was then allowed to cool down to r.t., washed with a saturated aqueous NaHCO3 (2ml) 
and concentrated under reduced pressure. Flash column chromatography (Pentane:EtOAc) 





Figure S5: Scope with Methoxy-amides. 
 
N-Methoxy-2-(1-methyl-1H-indol-3-yl)benzamide (15a) 
Starting from N-methoxybenzamide 14 (45.3 mg, 0.300 mmol), N-methoxy-2-
(1-methyl-1H-indol-3-yl)benzamide 15a (57.0 mg, 0.203 mmol, 68% yield) 
was obtained as a yellow oil. Rf: 0.4 (Pentane:EtOAc 2:1). 1H NMR (400 MHz, 
CDCl3) δ 7.98 (br s, 1H, NHOCH3), 7.74 (dd, J = 7.5, 5.9 Hz, 1H, ArH), 7.67 
(d, J = 7.9 Hz, 1H, IndoleH), 7.57 (dd, J = 7.8, 1.4 Hz, 1H, ArH), 7.52 (td, J = 
7.5, 1.4 Hz, 1H, ArH), 7.38 (m, 2H, ArH + IndoleH), 7.30 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H, IndoleH), 
7.24 (s, 1H, CH3NCHC), 7.18 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H, IndoleH), 3.85 (s, 3H, NCH3), 3.46 
(s, 3H, NHOCH3). 13C NMR (101 MHz, CDCl3) δ 168.4, 137.0, 132.5, 132.4, 130.8, 130.7, 129.5, 
128.1, 126.8, 126.7, 122.5, 120.3, 119.5, 113.5, 109.6, 63.9, 33.0. IR ν 3209 (w), 3057 (w), 2968 
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(w), 2934 (m), 2816 (w), 1655 (s), 1599 (w), 1547 (w), 1482 (s), 1464 (m), 1378 (m), 1329 (m), 
1223 (m), 1161 (w), 1034 (m), 944 (m), 885 (m). HRMS (ESI) calcd for 
C17H16N2NaO2+ [M+Na]+ 303.1104; found 303.1108 
 
N-Methoxy-4-methyl-2-(1-methyl-1H-indol-3-yl)benzamide (15b) 
Starting from N-methoxy-4-methylbenzamide 53 (50.0 mg, 0.300 mmol), N-
methoxy-4-methyl-2-(1-methyl-1H-indol-3-yl)benzamide 15b (30.0 mg, 0.102 
mmol, 34% yield) was obtained as a yellow oil. Rf: 0.44 (Pentane:EtOAc 2:1). 
1H NMR (400 MHz, CDCl3) δ 7.97 (br s, 1H, NHOCH3), 7.71 – 7.64 (m, 2H, 
ArH), 7.40 – 7.34 (m, 2H, ArH), 7.30 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H, ArH), 7.22 
– 7.16 (m, 3H, ArH), 3.85 (s, 3H, NCH3), 3.44 (s, 3H, NHOCH3), 2.42 (s, 3H, 
ArCH3). 13C NMR (101 MHz, CDCl3) δ 168.5, 141.1, 137.0, 132.4, 131.4, 129.7, 129.6, 128.0, 
127.7, 126.8, 122.5, 120.4, 119.6, 113.8, 109.6, 63.8, 33.0, 21.5. IR ν 3200 (w), 3047 (w), 2936 
(w), 1662 (s), 1615 (m), 1543 (w), 1482 (m), 1370 (w), 1331 (w), 1232 (w), 1160 (w), 1086 (w), 
1040 (w), 1015 (w), 912 (w), 887 (w), 834 (w). HRMS (ESI) calcd for C18H18N2NaO2+ [M+Na]+ 
317.1260; found 317.1264. 
 
N,4-Dimethoxy-2-(1-methyl-1H-indol-3-yl)benzamide (15c) 
Starting from N,4-dimethoxybenzamide 54 (54.5 mg, 0.300 mmol), N,4-
dimethoxy-2-(1-methyl-1H-indol-3-yl)benzamide 15c (85.0 mg, 0.274 mmol, 
91% yield) was obtained as a yellow oil. Rf: 0.48 (Pentane:EtOAc 2:1). 1H 
NMR (400 MHz, CDCl3) δ 8.02 (br s, 1H, NHOCH3), 7.75 (d, J = 8.6 Hz, 1H, 
ArH), 7.66 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.38 (d, J = 8.3 Hz, 1H, ArH), 7.30 
(ddd, J = 8.1, 7.0, 1.1 Hz, 1H, ArH), 7.22 (s, 1H, NCHC), 7.18 (ddd, J = 8.1, 
7.0, 1.1 Hz, 1H, ArH), 7.03 (d, J = 2.6 Hz, 1H, ArH), 6.92 (dd, J = 8.6, 2.6 Hz, 1H, ArH), 3.85 (s, 
3H, NCH3), 3.85 (s, 3H, OCH3), 3.43 (s, 3H, NHOCH3). 13C NMR (101 MHz, CDCl3) δ 168.1, 
161.3, 137.0, 134.3, 131.5, 128.0, 126.7, 124.8, 122.5, 120.4, 119.6, 115.7, 113.7, 112.5, 109.7, 
63.8, 55.4, 33.0. IR ν 3203 (w), 2961 (w), 2936 (w), 2838 (w), 1661 (s), 1603 (s), 1467 (m), 1330 
S72 
 
(m), 1279 (m), 1238 (m), 1214 (m), 1084 (m), 1030 (m), 886 (w). HRMS (ESI) calcd for 
C18H18N2NaO3+ [M+Na]+ 333.1210; found 333.1210. 
5-Fluoro-N-methoxy-2-(1-methyl-1H-indol-3-yl)benzamide (15d) 
Starting from 4-fluoro-N-methoxybenzamide 55 (50.7 mg, 0.300 mmol), 4-
bromo-N-methoxy-2-(1-methyl-1H-indol-3-yl)benzamide 15d (78.0 mg, 
0.243 mmol, 81% yield) was obtained as a yellow oil. Rf: 0.40 (Pentane:EtOAc 
2:1). 1H NMR (400 MHz, CDCl3) δ 8.03 (s, 1H, NHOCH3), 7.55 (d, J = 7.7 
Hz, 1H, ArH), 7.48 (m, 1H, ArH), 7.42 – 7.35 (m, 2H, ArH), 7.33 – 7.27 (m, 
2H, ArH), 7.23 (s, 1H, NCHC), 7.17 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 3.84 
(s, 3H, NCH3), 3.31 (s, 3H, NHOCH3). 13C NMR (101 MHz, CDCl3; two doublet were not 
resolved) δ 166.6, 160.1 (d, J = 247.4 Hz),  136.8, 135.2, 129.2, 128.6 (d, J = 8.5 Hz), 127.1, 125.0, 
122.5, 120.4, 119.9 (d, J = 2.2 Hz), 118.01 (d, J = 23.3 Hz), 109.6, 105.9, 63.6, 33.1. 19F NMR 
(376 MHz, CDCl3) δ -111.7. IR ν 3201 (w), 3055 (w), 2984 (w), 2938 (w), 1932 (w), 1663 (m), 
1551 (w), 1481 (m), 1455 (m), 1374 (m), 1330 (m), 1266 (s), 1245 (m), 1224 (m), 1161 (w), 1052 




Starting from 4-bromo-N-methoxybenzamide 56 (69.0 mg, 0.300 mmol), 4-
bromo-N-methoxy-2-(1-methyl-1H-indol-3-yl)benzamide 15e (91.0 mg, 0.253 
mmol, 84% yield) was obtained as an orange oil. Rf: 0.35 (Pentane:EtOAc 2:1).  
1H NMR (400 MHz, CDCl3) δ 8.04 (br s, 1H, NHOCH3), 7.75 (m, 1H, ArH), 
7.67 (d, J = 8.0 Hz, 1H, ArH), 7.39 (d, J = 8.2 Hz, 1H, ArH), 7.33 (m, 1H, 
ArH), 7.28 – 7.24 (m, 2H, ArH), 7.21 (m, 1H, ArH), 7.07 (td, J = 8.3, 2.6 Hz, 
1H, ArH), 3.85 (s, 3H, NCH3), 3.46 (s, 3H, NHOCH3). 13C NMR (101 MHz, CDCl3) δ 167.4, 
137.0, 134.6, 133.3, 131.2, 129.8, 128.4, 126.4, 125.2, 122.8, 120.7, 119.3, 112.3, 109.8, 63.9, 33.1 
(one Carbon signal not resolved). IR ν 3186 (w), 3063 (w), 2934 (w), 1656 (s), 1605 (s), 1580 (m), 
1480 (s), 1364 (w), 1331 (m), 1265 (s), 1195 (m), 1082 (w), 1037 (m), 986 (w), 939 (w), 887 (m), 





Starting from N-methoxy-3-methylbenzamide 57 (50.0 mg, 0.300 mmol), 
N-methoxy-5-methyl-2-(1-methyl-1H-indol-3-yl)benzamide 15f (44.0 mg, 
0.149 mmol, 50% yield) was obtained as a yellow oil. Rf: 0.40 
(Pentane:EtOAc 2:1). 1H NMR (400 MHz, CD2Cl2) δ 8.27 (s, 1H, ArH), 
8.24 (s, 1H, NHOCH3), 8.13 (dd, J = 8.1, 1.9 Hz, 1H, ArH), 7.67 (dd, J = 
9.9, 8.0 Hz, 2H, ArH), 7.41 (dt, J = 8.3, 0.9 Hz, 1H, ArH), 7.34 (s, 1H, ArH), 7.29 (ddd, J = 8.2, 
7.0, 1.1 Hz, 1H, ArH), 7.18 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 3.92 (s, 3H, NCH3), 3.85 (s, 3H, 
CH3), 3.49 (s, 3H, NHOCH3). 13C NMR (101 MHz, CD2Cl2) δ 166.7, 138.2, 137.8, 133.1, 131.8, 
131.2, 131.0, 129.5, 128.6, 127.0, 123.1, 121.0, 119.9, 113.3, 110.4, 64.3, 52.7, 33.6. IR ν 3181 
(w), 2932 (w), 1713 (s), 1660 (s), 1606 (m), 1538 (w), 1466 (w), 1437 (w), 1289 (m), 1262 (s), 
1248 (s), 1162 (w), 1128 (m), 1107 (m), 1038 (w). HRMS (ESI) calcd for C18H18N2NaO2+ 
[M+Na]+ 317.1260; found 317.1265. 
 
N-Methoxy-2-(1-methyl-1H-indol-3-yl)-5-(trifluoromethyl)benzamide (15g) 
Starting from N-methoxy-3-(trifluoromethyl)benzamide 58 (65.7 mg, 
0.300 mmol), N-methoxy-2-(1-methyl-1H-indol-3-yl)-5-
(trifluoromethyl)benzamide 15g (63.0 mg, 0.181 mmol, 60% yield) was 
obtained as a colorless oil. Rf: 0.37 (Pentane:EtOAc 2:1).  1H NMR (400 
MHz, CDCl3) δ 8.00 (br s, 1H, NHOCH3), 7.91 (s, 1H, ArH), 7.70 – 7.62 
(m, 2H, ArH), 7.59 (d, J = 8.0 Hz, 1H, ArH), 7.33 (m, 1H, ArH), 7.27 (m, 
1H, ArH), 7.24 (s, 1H, NCHC), 7.14 (ddd, J = 8.0, 6.9, 1.1 Hz, 1H, ArH), 3.79 (s, 3H, NCH3), 3.45 
(s, 3H, NHOCH3). 13C NMR (101 MHz, CDCl3) δ 167.1, 137.1, 136.4, 132.6, 130.9, 128.8, 128.7, 
127.3, 126.7, 126.4, 123.80 (q, J = 272.1 Hz, CF3), 122.8, 120.8, 119.2, 112.2, 109.9, 64.1, 33.1. 
19F NMR (376 MHz, CDCl3) δ -62.5. IR ν 3187 (w), 2978 (w), 2935 (w), 1657 (m), 1617 (w), 
1549 (w), 1469 (w), 1331 (s), 1274 (w), 1173 (m), 1159 (m), 1127 (s), 1092 (m), 947 (w), 911 (w), 






Starting from 3-fluoro-N-methoxybenzamide 59 (50.7 mg, 0.300 mmol), 4-
bromo-N-methoxy-2-(1-methyl-1H-indol-3-yl)benzamide 16h (84.0 mg, 
0.225 mmol, 75% yield) was obtained as a yellow oil. Rf: 0.38 
(Pentane:EtOAc 2:1). 1H NMR (400 MHz, CDCl3) δ 8.00 (br s, 1H, 
NHOCH3), 7.72 (d, J = 2.0 Hz, 1H, ArH), 7.64 (t, J = 9.1 Hz, 2H, ArH), 7.52 
(dd, J = 8.2, 2.0 Hz, 1H, ArH), 7.40 (m, 1H, ArH), 7.32 (dd, J = 7.0, 1.2 Hz, 1H, ArH), 7.25 (s, 
1H, NCHC), 7.21 (ddd, J = 8.0, 6.9, 1.1 Hz, 1H, ArH), 3.85 (s, 3H, NCH3), 3.45 (s, 3H, NHOCH3). 
13C NMR (101 MHz, CDCl3) δ 167.6, 163.8 (d, J = 250.9 Hz), 137.0, 135.4, 135.3 (d, J = 9.4 Hz), 
131.8 (d, J = 9.5 Hz),  128.4, 128.3, 126.4, 122.7, 120.7, 117.10 (d, J = 21.5 Hz), 113.79 (d, J = 
21.9 Hz), 112.5, 109.8, 63.9, 33.1. 19F NMR (376 MHz, CDCl3) δ -109.3. IR ν 3179 (w), 3055 
(w), 2932 (m), 2853 (w), 1662 (s), 1586 (m), 1550 (w), 1479 (s), 1329 (w), 1256 (w), 1222 (w), 
1163 (w), 1089 (m), 1038 (m), 956 (w), 911 (m), 882 (m), 824 (w). HRMS (ESI) calcd for 
C17H15FN2NaO2+ [M+Na]+ 321.1010; found 321.1011. 
 
5-Chloro-N-methoxy-2-(1-methyl-1H-indol-3-yl)benzamide (15i) 
Starting from 3-chloro-N-methoxybenzamide 60 (55.7 mg, 0.300 mmol), 
N-methoxy-2-(1-methyl-1H-indol-3-yl)-5-(trifluoromethyl)benzamide 15i 
(70.9 mg, 0.225 mmol, 75% yield) was obtained as a yellow oil. Rf: 0.35 
(Pentane:EtOAc 2:1).  1H NMR (400 MHz, CDCl3) δ 7.81 (br s, 1H, 
NHOCH3), 7.64 (dd, J = 8.0, 1.3 Hz, 1H, ArH), 7.60 (d, J = 7.7 Hz, 1H, 
ArH), 7.45 – 7.37 (m, 2H, ArH), 7.35 (d, J = 7.9 Hz, 1H, ArH), 7.29 (m, 1H, ArH), 7.19 (s, 1H, 
NCHC), 7.15 (t, J = 7.5 Hz, 1H, ArH), 3.87 (s, 3H, NCH3), 3.15 (s, 3H, NHOCH3). 13C NMR (101 
MHz, CDCl3) δ 166.9, 137.0, 133.6, 132.7, 132.0, 131.1, 130.9, 129.5, 128.2, 126.6, 122.7, 120.6, 
119.3, 112.3, 109.8, 64.0, 33.1. IR ν 3185 (w), 3058 (w), 2931 (m), 2852 (w), 1656 (s), 1543 (w), 
1482 (m), 1466 (m), 1374 (w), 1330 (w), 1256 (w), 1163 (w), 1100 (m), 1041 (w), 943 (m), 824 






Starting from N-methoxybenzo[d][1,3]dioxole-5-carboxamide 61 (58.6 mg, 
0.300 mmol), N-methoxy-6-(1-methyl-1H-indol-3-yl)benzo[d][1,3]dioxole-
5-carboxamide 15j (78.0 mg, 0.240 mmol, 80% yield) was obtained as a 
white oil. Rf: 0.48 (Pentane:EtOAc 2:1). 1H NMR (400 MHz, CD2Cl2) δ 
7.49 (d, J = 8.0 Hz, 1H, ArH), 7.40 (d, J = 8.3 Hz, 1H, IndoleH), 7.33 – 7.25 
(m, 3H, IndoleH), 7.14 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H, ArH), 6.85 (d, J = 8.1 
Hz, 1H, IndoleH), 6.01 (s, 2H, OCH2O), 3.84 (s, 3H, NCH3), 3.35 (s, 3H, NHOCH3). (NHOMe 
proton present at 8.2 ppm) 13C NMR (101 MHz, CD2Cl2; the signals of two aromatic carbons were 
not resolved) δ 166.8, 149.5, 146.1, 137.0, 129.4, 127.1, 126.9, 124.1, 122.4, 120.2, 115.2, 109.8, 
107.0, 106.8, 101.7, 63.6, 33.1. IR ν 3191 (w), 2967 (w), 2934 (w), 2899 (w), 1656 (m), 1628 (m), 
1480 (m), 1448 (s), 1374 (w), 1340 (m), 1250 (s), 1224 (w), 1132 (w), 1040 (s), 1017 (w), 929 (m), 
833 (w). HRMS (ESI) calcd for C18H16N2NaO4+ [M+Na]+ 347.1002; found 347.1002. 
 
N-Methoxy-2-(1-methyl-1H-indol-3-yl)-1-naphthamide (15k) 
Starting from N-methoxy-1-naphthamide 62 (60.4 mg, 0.300 mmol), N-
methoxy-2-(1-methyl-1H-indol-3-yl)-1-naphthamide 15k (78.0 mg, 0.236 
mmol, 79% yield) was obtained as a colorless oil. Rf: 0.35 (Pentane:EtOAc 
2:1). 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 8.5 Hz, 1H, ArH), 8.00 – 
7.95 (m, 2H, ArH + NHOCH3), 7.89 (m, 1H, ArH), 7.80 (t, J = 8.6 Hz, 2H, 
ArH), 7.58 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H, ArH), 7.52 (ddd, J = 8.1, 6.9, 1.3 Hz, 1H, ArH), 7.41 (d, 
J = 9.7 Hz, 2H, ArH), 7.32 (m, 1H, ArH), 7.22 (m, 1H, ArH), 3.86 (s, 3H, NCH3), 3.66 (s, 3H, 
NHOCH3). 13C NMR (101 MHz, CDCl3) δ 168.3, 137.1, 131.8, 131.3, 131.1, 130.0, 128.9, 128.5, 
128.0, 127.6, 127.4, 126.9, 126.0, 124.8, 122.3, 120.2, 119.4, 113.1, 109.8, 64.0, 33.0. IR ν 3186 
(w), 3056 (w), 2958 (w), 2929 (m), 2854 (w), 1651 (s), 1615 (m), 1545 (w), 1479 (m), 1384 (w), 
1339 (w), 1264 (w), 1230 (w), 1134 (w), 1101 (w), 1074 (m), 1019 (m), 892 (w), 821 (s). HRMS 




5. Crystal Structure and DSC Measurements. 
 
A single crystal was grown by slow diffusion of the solution of 9b in MeOD/CCl4 mixture. 
Supplementary crystallographic data for this compound have been deposited at Cambridge 
Crystallographic Data Centre (1540821) and can be obtained free of charge via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
A single crystal was grown by slow diffusion of the solution of 9m in MeOD/CCl4 mixture. 
Supplementary crystallographic data for this compound have been deposited at Cambridge 




DSC measurements of compound 9a  
 
 




  normalized 61.12 J g^ -1
Peak Height 0.34 mW
Peak 289.54 °C
Extrapol. Peak 289.56 °C
Peak Width 69.66 °C
Left Limit 220.94 °C
Right Limit 346.68 °C
Heating Rate 4.00 °Cmin^-1
Integral 24.01 mJ
  normalized 4.46 Jg^-1
Peak Height 0.10 mW
Peak 119.94 °C
Extrapol. Peak 113.21 °C
Peak Width 16.28 °C
Left Limit 103.95 °C
Right Limit 134.74 °C
Heating Rate 4.00 °Cmin^-1
Integral 1518.83 mJ
  normalized 282.31 Jg^-1
Peak Height 17.29 mW
Peak 182.78 °C
Extrapol. Peak 182.75 °C
Peak Width 3.69 °C
Left Limit 150.58 °C
Right Limit 202.03 °C
Heating Rate 4.00 °Cmin^-1
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ST AR e SW 12. 10SYNGENT A:  CPR Analy t ics
Integral 265.81 mJ
  normalized 57.78 J g^ -1
Peak Height 0.32 mW
Peak 319.00 °C
Extrapol. Peak 353.89 °C
Peak Width 53.48 °C
Heating Rate 4.00 °Cmin^-1
Integral 2640.75 mJ
  normalized 574.08 Jg^-1
Peak Height 41.06 mW
Peak 214.99 °C
Extrapol. Peak 214.87 °C
Peak Width 1.75 °C
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  normalized 546.53 Jg^-1
Peak Height 26.82 mW
Peak 202.60 °C
Extrapol. Peak 202.58 °C
Peak Width 3.30 °C
Left Limit 165.53 °C
Right Limit 285.53 °C
Heating Rate 4.00 °Cmin^-1
Integral 149.68 mJ
  normalized 27.31 J g^ -1
Peak Height 0.49 mW
Peak 79.43 °C
Extrapol. Peak 79.21 °C
Peak Width 22.52 °C
Left Limit 77.58 °C
Right Limit 108.37 °C
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1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S81 
 
















































































































































































































































































1H-NMR (400 MHz, DMSO-d6) 
13C-NMR (101 MHz, DMSO-d6) 
S82 
 































































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S83 
 





































































































































































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S84 
 










































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S85 
 










































































































































































































































13C-NMR (101 MHz, CDCl3) 
1H-NMR (400 MHz, CDCl3) 
S86 
 















































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S87 
 











































































































































































































































































































1H-NMR (400 MHz, CD3OD) 
13C-NMR (101 MHz, CD3OD) 
S88 
 

















































































































































































































1H-NMR (400 MHz, CD3OD) 
13C-NMR (101 MHz, CD3OD) 
S89 
 









































































































































1H-NMR (400 MHz, CDCl3) 




































































































































































































13C-NMR (101 MHz, CD2Cl2) 
1H-NMR (400 MHz, CD2Cl2) 
S91 
 






















































































































































































































1H-NMR (400 MHz, CD2Cl2) 
13C-NMR (101 MHz, CD2Cl2) 
S92 
 













































































































































































































13C-NMR (101 MHz, CD3OD) 
1H-NMR (400 MHz, CD3OD) 
S93 
 





























































































































































































1H-NMR (400 MHz, CD3OD) 
13C-NMR (101 MHz, CD3OD) 
S94 
 




















































































































































































































1H-NMR (400 MHz, CD3OD) 
13C-NMR (101 MHz, CD3OD) 
S95 
 


































































































































































































































































1H-NMR (400 MHz, CD3OD + C6D6) 
13C-NMR (101 MHz, CD3OD + C6D6) 
S96 
 



































































































































































































































1H-NMR (400 MHz, CD3OD + C6D6) 
13C-NMR (101 MHz, CD3OD + C6D6) 
S97 
 















































































































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S98 
 









































































































































































13C-NMR (101 MHz, CDCl3) 
1H-NMR (400 MHz, CD3OD) 
S99 
 





























































































































































β-Phenyliodonioindole Tetrafluoroborate (18). 
1H-NMR (400 MHz, CDCl3) 

































































































































































































1-Methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13a)  
4
1H-NMR (400 MHz, DMSO-d6) 








































































































































































































































































































3-(2-(Pyridin-2-yl)phenyl)-1H-indole (13b)  
13C-NMR (101 MHz, CDCl3) 
1H-NMR (400 MHz, CDCl3) 
S102 
 

















































































































































































































































































1-(3-Phenylpropyl)-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13c)  
1H-NMR (400 MHz, CDCl3) 




































































































































































































































































5-Methoxy-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13d)  
1H-NMR (400 MHz, CDCl3) 




























































































































































































































































































5-Fluoro-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13e)  
1H-NMR (400 MHz, CDCl3) 
1H-NMR (400 MHz, CDCl3) 






















































































































































































































































































5-Chloro-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13f)  




































































































































































































































































5-Iodo-1-methyl-3-(2-(pyridin-2-yl)phenyl)-1H-indole (13g)  
13C-NMR (101 MHz, CDCl3) 
















































































































































































































































































1H-NMR (400 MHz, CDCl3) 
























































































































































































































































































































13C-NMR (101 MHz, CDCl3) 
1H-NMR (400 MHz, CDCl3) 
S109 
 
2-(2-(1-Methyl-1H-pyrrol-3-yl)phenyl)pyridine (13i)  
























































































































































































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S110 
 
































































































































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S111 
 






































































































































































































































































































1H-NMR (400 MHz, CDCl3) 


























































































































































































































































































1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
S113 
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